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ABSTRACT 
 
REGULATION OF DYNEIN-DEPDENDENT NEURONAL  
TRANSPORT AND TRAFFICKING BY CDK5 
Eva Klinman 
Dr. Erika Holzbaur 
 
 
Neurons have a distinct structure; they are the only cells in the body whose proximal and 
distal ends can be separated by more than a meter. This leads to unique challenges for 
the neuron, specifically, how proteins, organelles, and other cargo synthesized in the cell 
body are specifically trafficked from the soma to the distal end of the axon, and how 
degradative cargo and signaling factors are transported from the terminal to the cell 
body. Using primary cultured central and peripheral neurons isolated from the brains and 
spinal cords of rats or mice, we sought to determine if a neuronal-specific kinase, cyclin 
dependent kinase 5 (CDK5) regulates the motility of cargo moving along the axon, and if 
this kinase also regulates the localized exclusion of somatodendritic cargo from the 
axon. Within the mid-axon, we observed that baseline CDK5 activity was not required to 
regulate axonal transport, but pathological activation of CDK5 via a stress-associated 
activator disrupted both anterograde (outward) and retrograde (inward) motility. In 
contrast, within the axon initial segment (AIS), inhibition of normal CDK5 activity 
disrupted cytoskeletal structure and compromised axonal and dendritic sorting, 
aberrantly permitting the entry of somatodendritic cargos into the axon. We determined 
that both roles of CDK5 in axonal regulation were dependent on phosphorylation of its 
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target Ndel1, a protein that regulates the interaction of the retrograde microtubule-based 
motor dynein with its cofactor Lis1. In the mid-axon, high levels of CDK5 activity causes 
dynein to tightly bind along the microtubule interrupting processive motility, while in the 
AIS, CDK5 activity is required to initiate dynein-driven return of somatodendritic cargo to 
the cell body. Together theses studies demonstrate the importance of CDK5 activity in 
the regulation of transport within the neuron.  
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CHAPTER 1 
Introduction: CDK5, Transport, Diseases, and 
Neurons 
 
 
 
 
1.1 Cyclin Dependent Kinase 5 
Cyclin dependent kinase 5 (CDK5) is an atypical serine- and threonine- directed 
neuronal kinase. Unlike other cyclin dependent kinases, CDK5 is neither cyclin 
dependent, nor expressed in cycling cells (Paglini and Cáceres, 2001). Rather, its 
expression is limited to post-mitotic neurons. CDK5 was named for sequence homology 
to CDK2, a typical cyclin dependent kinase (Hellmich et al., 1992; Lew et al., 1992; 
Meyerson et al., 1992). Shortly after discovery of the kinase, the consensus 
phosphorylation site recognized by CDK5 was identified. CDK5 phosphorylates the 
serine or theronine in the sequence is S/TPXK/R; the immediate downstream proline is 
required to direct phosphorylation, while the basic lysine or arginine at the +3 location is 
preferred but not necessary (Brown et al., 1999; Shetty et al., 1993). 
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CDK5 has two known activators, p35 and p39. In healthy neurons, p35 is the 
predominant binding partner (Lew et al., 1994; Uchida et al., 1994). Both p35 and p39 
are small membrane-tethered proteins (Tang et al., 1995). Under normal conditions, 
CDK5 forms an active complex with p35 at the neuronal membrane (Delalle et al., 1997; 
Ko et al., 2001; Sharma et al., 1999). Binding to p35 causes a conformation change in 
CDK5: an unfolding of its 20-residue activation loop (Mapelli and Musacchio, 2003). The 
active p35/CDK5 complex results in self-phosphorylation of p35 on serine 8 and 
threonine 138, and subsequent ubiquinitation and breakdown (Kamei et al., 2007; 
Patrick et al., 1998). As a result, the p35/CDK5 kinase complex is only active for 
approximately 20 minutes, and remains spatially regulated, tethered to the membrane.  
Under conditions of cellular stress, calcium influx into the cell activates calpain, 
which cleaves p35 into a membrane-bound p10 subunit and a cytoplasmic p25 subunit 
(Lee et al., 2000; Patrick et al., 1999). The p25 subunit contains the catalytically active 
domain for binding CDK5, but not the phosphorylation and ubiquinitation site. As a 
result, the p25/CDK5 complex is active for three times longer than the p35/CDK5 
complex, and loses tightly regulated spatial specificity. p39 is similarly affected by 
calpain, resulting in cleavage to p10 and p29 (Patzke et al., 2003).  
CDK5 controls many crucial cellular functions, and is required for proper brain 
development. Knock-out animals experience embryonic lethality due to lack of neuronal 
migration from the ventricular zone (Ohshima et al., 1996), although CDK5-null worms 
are viable (Ou et al., 2010). CDK5 is necessary for cytoskeletal regulation (Hallows et 
al., 2003), axon guidance (Nikolic et al., 1996), cellular transport (Barclay et al., 2004; 
Paglini and Cáceres, 2001; Shea et al., 2004), and synaptic function (Cheng and Ip, 
2003). 
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CDK5 Substrate Post-phosphorylation effects References 
β-APP Increased Aβ production, decreased 
transport 
Maccioni et al., 2001; 
Smith, 2003 
Ndel1 Increased affinity for Lis1 and dynein, 
and dynein for microtubules 
Dhavan and Tsai, 2001; 
Smith, 2003 
Tau Disorganization of microtubules, 
disruption of transport 
Flaherty et al., 2000; Lee 
and Tsai, 2003; Mapelli 
and Musacchio, 2003 
Neurofilament Reduction of transport Grant et al., 2001; Li et 
al., 2000; Smith, 2003 
Src Altered cell adhesion, actin dynamics Smith and Tsai, 2002 
Axin Activation of CRMP2, axon elongation Fang et al., 2011 
CRMP2 Growth cone collapse Brown et al., 2004 
MAP1B Axon elongation, increased transport Paglini et al., 1998 
Doublecortin Inhibition of neuronal migration Tanaka et al., 2004 
Stathmin Release of sequestered tubulin Hayashi et al., 2006 
PPI Inhibition of GSK3β, activation of 
kinesin 
Morfini et al., 2004 
MAP2 Axonal abnormalities Bu et al., 2002 
 
Table 1.1: Overview of CDK5 phosphorylation substrates involved in regulation of 
microtubules. 
First column indicates direct substrate of CDK5 phosphorylation. Second column lists 
the consequences of CDK5-mediated protein phosphorylation on neuronal microtubules. 
Corresponding references in the third column.  
 
The various functions of CDK5 are carried out through phosphorylation of 
numerous target proteins, including those involved in axonal transport and regulation of 
microtubules (Table 1.1). Of particular interest is the protein NudE-like 1 (Ndel1). 
Phosphorylation of Ndel1 on five serine and threonine residues (T198, T219, S231, 
S242, and T245) by CDK5 enhances the binding of Ndel1 to its cofactor Lis1 
(Niethammer et al., 2000; Zyłkiewicz et al., 2011). Ndel1 and Lis1 are required for proper 
brain development, and haploinsufficiency of Lis1 causes type 1 lissencephaly (Cardoso 
et al., 2002). The Ndel1/Lis1 complex is found in many neuronal cell types, and acts to 
regulate transport of the microtubule-based motor protein dynein (See Section 1.3) 
(Tarricone et al., 2004). As a result, CDK5-dependent phospho-Ndel1 and Lis1 are 
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required for proper neuronal development (Tsai et al., 2005), migration (Shu et al., 
2004), and neurogenesis (Yingling et al., 2008) 
 
 
1.2 The Neuronal Cytoskeleton 
Neurons have a complicated shape and unique structure that requires significant support 
from cytoskeletal proteins. These proteins assist in maintaining neuronal structure and 
form the backbone that permits short- and long-distance transport. The primary 
complexes involved are microfilaments and microtubules.  
 
Microfilaments 
Actin-based microfilaments are the thinnest of the cytoskeletal support proteins, at 6 nm 
in diameter (Resch et al., 2002). In neurons, actin filaments play roles in cell motility, 
polarity, neurite growth, growth cone development and maintenance, and dendritic spine 
formation and maintenance (Coles and Bradke, 2015; Craig et al., 2012; Jones et al., 
2014; Kevenaar and Hoogenraad, 2015; Mallavarapu and Mitchison, 1999; Watanabe et 
al., 2012). Interestingly, the distribution of microfilaments within the dendrites is different 
than that found in the axon. In dendrites, actin forms long filaments that run roughly 
parallel to the length of the dendrite, with occasional bridges crossing neighboring 
filaments in a haphazard arrangement (Chazeau et al., 2014, 2015). In contrast, axonal 
actin is far more structured. Within the axon, actin forms three distinct structures: rings, 
patches, and comets (D’Este et al., 2015; Ganguly et al., 2015; Letourneau, 1983; 
Spillane et al., 2011; Xu et al., 2012). Actin rings and patches are stable arrangements 
of actin filaments, while comets are dynamic and can propel cargo around within the 
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axon (D’Este et al., 2015; Ganguly et al., 2015; Xu et al., 2013). Microfilaments also form 
a web-like structure in axonal growth cones (Letourneau, 1983).  
Free actin within the neuron is termed G-actin. ATP-actin monomers are added 
to the dynamic barbed end of an actin filament (Campellone and Welch, 2010; von der 
Ecken et al., 2015). Reduction of actin filament length occurs at the pointed end, which 
contains ADP-actin (Craig et al., 2012). Various proteins assist in adding new G-actin 
monomers to the growing actin filament, including profilin, formins, and the branching 
protein Arp2/3 (Chesarone et al., 2010; Smith et al., 2013; Spillane et al., 2011; Strasser 
et al., 2004; Vitriol et al., 2015). Depolymerization is enhanced by severing factors such 
as cofilin (Flynn et al., 2012). Other proteins, β-thymosin and Eps8 limit growth rate by 
sequestering G-actin or capping the barbed end respectively (Menna et al., 2009; Vitriol 
et al., 2015).  
Within the axon, the best-characterized actin filament structures are parallel rings 
that run the length of the axon starting in the AIS. These rings have a characteristic 
spacing of ~180 nm, and are interspersed with the scaffold protein spectrin (D’Este et 
al., 2015; Xu et al., 2012, 2013). Actin patches and hotspots exist within the axon, and 
form thicker webs of filamentous actin, with hotspots identified as a site for dynamic 
actin-driven motility (Ganguly et al., 2015; Spillane et al., 2011).  
Myosin is the dedicated actin-based molecular motor, but is not responsible for 
long-distance transport in neurons. Two well-characterized myosin motors, myosin Va 
and VI are expressed in neurons. Myosin Va is a barbed-end directed motor (Cheney et 
al., 1993) while myosin VI is a pointed-end directed motor (Wells et al., 1999). Myosin 
Va localizes to filamentous actin patches and recruits passing cargo to the patches by 
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drawing them onto microfilaments and off of microtubules. Additionally, myosin Va 
directs somatodendritic proteins to the dendrite (Lewis et al., 2009). Myosin works in 
concert with the molecular motors dynein and kinesin (See Section 1.3) to direct 
trafficking and transport of cargo, but on its own is not sufficient for long-distance 
directed transport.  
 
Microtubules 
Microtubules composed of tubulin form the tracks upon which many motor proteins 
move. Where actin exists thin filaments, tubulin dimers assemble into large hollow tubes 
– microtubules – with a 25 nm diameter that provide rigidity to the neuron. These large 
tubes stretch an average of approximately 100 microns in mature neurons, but can vary 
between very short and very long (Bray and Bunge, 1981).  
Microtubules are typically composed of 13 protofilaments, made of alternating α- 
and β- tubulin heterodimers. The heterodimers bind head-to-tail, to create a structurally 
polarized superstructure (Akhmanova and Steinmetz, 2008). The minus-end of the 
microtubule contains exposed α-tubulin, while the plus-end exhibits the β-tubulin side. 
Stabilization of the static minus-end is performed by -TIP binding proteins, such as 
CAMSAP, Patronin, and Nezha (Goodwin and Vale, 2010; Hendershott and Vale, 2014). 
The majority of microtubule polymerization and depolymerization takes place at the 
dynamic plus-end, which associates with +TIP binding proteins such as end binding 
protein 1 and 3 (EB1 and EB3) (Stepanova et al., 2003). These microtubule-associated 
+ and - TIP proteins control various aspects of neuronal development and function via 
regulation of microtubule dynamics (Moughamian et al., 2013; Stepanova et al., 2003). 
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Other proteins, such as tau, bind to the microtubule lattice and assist in the stabilization 
of axonal microtubules (Binder et al., 1985; Conde and Cáceres, 2009).  
Microtubules are dynamic structures, frequently undergoing alternating periods of 
growth and then rapid shortening. As a result, microtubules can be short-lived. However, 
comparatively stable microtubules are also present in neurons (Baas and Black, 1990). 
These longer-lived microtubules tend to acquire post-translational modifications which 
protect them from depolymerization, such as acetylation. Other changes which 
accumulate on stable microtubules include tyrosination/detyrosination, glutamylation, 
and phosphorylation (Hammond et al., 2008; Janke and Kneussel, 2010). Intriguingly, 
certain regions of the neuron tend to be enriched for specific types of post-translational 
modifications (Hammond et al., 2010).  
Dendrites and axons of mammalian neurons display different orientations of 
microtubules. In large proximal dendrites, microtubules exhibit mixed polarity, displaying 
both their plus- and minus- end towards the cell body (Burton, 1988). In contrast, axonal 
microtubules are uniformly plus-end-out, with the stabilized minus-end facing towards 
the cell body (Baas and Lin, 2011; Baas et al., 1988). Individual regions of axons can 
contain between 10 and 100 individual similarly-oriented microtubules, which are often 
arranged into bundles (Fadić et al., 1985). In smaller non-neuronal cells, the minus-end 
of microtubules is positioned within the microtubule organizing center (MTOC) (Takitoh 
et al., 2012) near the centrioles, embedded in γ-tubulin. However, the length of axons 
and dendrites necessitates non-centriolar microtubules as well. Neuronal de novo axonal 
microtubule formation is still nucleated by γ-tubulin, but not exclusively from within the 
cell body (Kollman et al., 2011). The end result is parallel-oriented plus-end-out bundles 
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of microtubules with varying lengths in the axon, and mixed polarity microtubules in the 
dendrites.  
Microtubules serve a variety of functions in neurons. They provide tracks for 
intracellular transport (Hirokawa et al., 2010; Maday et al., 2014), acting as the base 
upon with dynein and kinesins move cargo (See Section 1.3). Microtubules also provide 
local clues to help determine positioning of organelles within the neuron (de Forges et 
al., 2012). Additionally, they can act as signaling devices (Akhmanova and Steinmetz, 
2008). As a result, the dynamics of neuronal microtubules are tightly regulated. 
 
Intermediate Filaments 
Intermediate filaments are a diverse group of proteins, classified by having a diameter of 
10 nm. There are 6 classes of intermediate filaments, which are expressed in various 
cell types (Kornreich et al., 2015a). In neurons, different intermediate filaments are 
expressed at different times during development, with neurofilaments being the primary 
intermediate filaments in mature neurons. (Fliegner et al., 1994; Laser-Azogui et al., 
2015). 
Neurofilaments are composed of three subunits, a light, medium, and heavy 
chain. Like other intermediate filaments, neurofilaments have a structured α-helical rod 
domain and disordered N- and C- terminal head and tail domains (Guharoy et al., 2013). 
The assembly of neurofilaments is complex, involving the formation of anti-parallel 
dimers, staggered tetramers, and further association of 8 tetramers into filaments that 
are then radially compressed into 10 nm filaments (Hesse et al., 2008; Kornreich et al., 
2015b). As only the helical portions of neurofilaments associate with each other, the 
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disordered domains stick out from the filament like a brush, allowing neurofilaments to 
physically cushion and expand nearby cytoplasm (Herrmann et al., 1999; Kornreich et 
al., 2015b; Lowery et al., 2015). 
Less is understood about neurofilaments than microfilaments and microtubules. 
The primary function of neurofilaments appears to be increasing the width of myelinated 
axons to aid in fast condition of action potentials. They also contribute to organelle 
distribution and cell polarity (Kim and Coulombe, 2007; Toivola et al., 2005). 
 
1.3 Axonal Transport 
All neurons, regardless of the neuronal type, extend long processes from the cell body. 
The length of these extensions renders neurons uniquely reliant on active intracellular 
transport to move proteins and organelles to and from the cell body. Newly synthesized 
proteins and organelles must be moved from the cell soma out to the dendrites and 
axon, while signaling endosomes and damaged organelles must be returned to the cell 
body from the periphery (Ashrafi et al., 2014; Iacobucci et al., 2014; Lasiecka and 
Winckler, 2011; Maday et al., 2012). Disruption of axonal transport has been linked to 
neurodegeneration and disease (See Section 1.4). 
Proper trafficking and transport of individual cargo is dependent on the 
differential activation of the two microtubule-based motor proteins, dynein and kinesin 
(Fu and Holzbaur, 2013). Both the anterograde kinesin and retrograde dynein motors 
are attached to most cargos, but only one type of motor may actively engage the 
microtubule at a time, thus controlling directional motility during transport (Hancock, 
2014; Hendricks et al., 2010; Maday et al., 2014). For cargos which move bidirectionally, 
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kinesin and dynein alternate control of cargo movement (Hendricks et al., 2010; Müller et 
al., 2008). In contrast, cargos with unidirectional motion rely on inhibition of the unused 
motor protein (Fu and Holzbaur, 2014).  
Control of motor protein-driven transport can occur at the level of the motor 
protein, adaptor proteins, or the cargo itself. For kinesin-1, autoinhibition is relieved by 
adaptor scaffolding proteins (Blasius et al., 2007; Fu and Holzbaur, 2014). Adaptor 
proteins can broadly regulate motility directly: Rab GTPases recruit cargos to motor 
proteins (Akhmanova and Hammer, 2010), and huntingtin/HAP1 coordinates motility of a 
wide range of cargos (Maday et al., 2014; Wong and Holzbaur, 2014). In contrast, 
mitochondria are individually regulated by the Miro/TRAK complex (MacAskill et al., 
2009; Wang and Schwarz, 2009), and JIP proteins regulate signaling endosomes and 
APP-positive vesicles (Fu and Holzbaur, 2013). Regardless, the motor proteins 
themselves are directly responsible for axonal transport, and undergo specific regulation. 
 
Anterograde transport: Kinesin 
Kinesins are a family of motor proteins that predominantly traffic towards the plus-end of 
axonal microtubules. As a result, kinesins appear to move anterograde, down the axon 
towards the axon terminal. There are 14 kinesin subfamilies, of which three are involved 
in axonal transport: kinesin-1, -2, and -3, and all of which use ATP hydrolysis to power 
motility (DeBerg et al., 2013; Maday et al., 2014). 
The kinesin-1 family of proteins accomplishes the majority of fast anterograde 
axonal transport. Kinesin-1 is composed of two heavy chains and frequently two light 
chains (Sun et al., 2011), which are involved in cargo binding and autoinhibition of the 
protein. Kinesin-2 and kinesin-3 operate slightly differently from kinesin-1, in that kinesin-
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2 can be composed of a dimer or trimer of proteins while kinesin-3 assembles into a 
processive dimer upon cargo binding (Scholey, 2013; Soppina et al., 2014).  
Kinesins are required for all anterograde-directed axonal transport. Chief among 
these is the transport of maintenance and survival signals down the axon (Delcroix et al., 
2004). Precursor proteins for synaptic vesicles and dense core vesicles are also 
transported from the cell body down to the necessary presynaptic axon terminals (Chua 
et al., 2012; Okada et al., 1995) 
Kinesins are somewhat self-regulatory, in that they contain an auto-inhibition 
motif which releases the motor domain upon binding to scaffold proteins or cargo 
(Blasius et al., 2007; Fu and Holzbaur, 2013; Kaan et al., 2011; Sun et al., 2011). 
Specific proteins which regulate kinesin activation have been identified, such as Mint1 in 
the trafficking of NMDA receptors (Guillaud et al., 2008; Setou et al., 2000), and 
DENN/MADD in control of synaptic vesicles (Niwa et al., 2008). Once kinesin has been 
freed of autoinhibition, the protein is highly motile. In contrast, dynein requires co-
regulatory proteins to enhance its processivity (Haghnia et al., 2007). 
 
Retrograde transport: Dynein 
Dynein is the primary minus-end directed microtubule motor, and as such moves cargo 
retrograde within the axon. Dynein motility is based of cycles of binding and releasing 
ATP. Hydrolysis of ATP induces dynein binding to the microtubule, and release of the 
cleaved phosphate results in a powerstroke. Binding of ATP to dynein reduces the 
affinity of dynein for tubulin, and causes dynein to release the microtubule (Carter et al., 
2008; Porter and Johnson, 1983). The dynein complex is an association of 2 heavy 
chains, 2 intermediate chains, 2 intermediate light chains, and 6 light chains (Kuta et al., 
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2010; Mitchell et al., 2012; Salata et al., 2001; Zhang et al., 2013). Although other forms 
of dynein exist, only one form – cytoplasmic dynein – is responsible for retrograde 
axonal transport (Kuta et al., 2010).  
Dynein is responsible for the retrograde movement of proteins, vesicles, 
organelles, and recycling endosomes in the axon (Höök and Vallee, 2006; Kikkawa, 
2013). Dynein also aids in maintenance of Golgi vesicles and organization of the 
neuronal cytoskeleton. In dendrites, dynein continues to govern transport, although due 
to cytoskeletal structure it is not necessarily a retrograde-directed motor (Kapitein et al., 
2010; van Spronsen et al., 2013; Zheng et al., 2008). 
Many adaptor proteins interface with dynein to control its motility and binding to 
microtubules or cargo. Dynactin is the primary adaptor protein, which itself contains 
numerous smaller proteins in complex. Dynactin is a positive regulator of dynein motility 
that binds both dynein and microtubules, and mediates dynein-cargo interactions (Gill et 
al., 1991; Schroer, 2004). BICD is another regulator of dynein motility which aids in 
dynein-cargo interactions. It functions by linking dynein to cargo, stabilizing the 
interaction of dynein and dynactin, and coordinating motor recruitment (Dienstbier et al., 
2009; Hoogenraad and Akhmanova, 2016; Hoogenraad et al., 2003). Both dynactin and 
BICD are crucial for proper dynein motility and cargo binding, and mutations in either 
result in reduced dynein function (Lipka et al., 2013). 
The protein Lis1 (first identified as PAFAH1B1) is a negative regulator of dynein 
motility, unlike dynactin and BICD. Recruitment of Lis1 to dynein and subsequent 
regulation of motility depends on Ndel1. The Ndel1/Lis1 complex binds to the dynein 
heavy chain and causes dynein to clamp onto the microtubule, which aids in transport 
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initiation (Egan et al., 2012; Huang et al., 2012; Sasaki et al., 2000), but interrupts active 
transport (Klinman and Holzbaur, 2015). Unlike dynactin and BICD, Lis1 does not move 
with dynein. Rather, the Ndel1/Lis1 complex has been proposed to fall off the dynein 
motor, permitting unimpeded motility (Egan et al., 2012). As a result of its regulation of 
dynein, mutations in Lis1 cause defects of neuronal migration that result in lissencephaly 
(Vallee and Tsai, 2006).  
 
1.4 Diseases Associated with Axonal Transport and CDK5  
Axonal transport is disrupted in a number of neurodegenerative diseases. A common 
theme involves mutations or misregulation of dynein resulting in morphological 
abnormalities in mitochondria, which often exacerbate neuronal dysfunction (Eschbach 
et al., 2013). Disruption of dynein-driven motility also directly interrupts transport of 
necessary survival factors (Perlson et al., 2009). Through these mechanisms and others, 
axonal transport is involved the pathology of Alzheimer’s disease (AD), motor neuron 
diseases, Huntington’s disease (HD), and Parkinson’s disease (PD). There are many 
other diseases that result from defects in dynein- and kinesin- driven transport, primarily 
developmental diseases which issue from neuronal migration defects (Willemsen et al., 
2012). Increased levels of CDK5 activity due to p25 expression is also observed in a 
number of neurodegenerative diseases, resulting in hyperphosphorylation of target 
proteins and further disruption of axonal transport. 
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Alzheimer’s Disease 
AD is a disease of progressive memory loss and neurodegeneration, stemming from 
accumulation of protein aggregates. The two primary aggregates, beta amyloid (Aβ) 
plaques and tau-containing neurofibrillary tangles, disrupt axonal transport in affected 
neurons. Tangles of hyperphosphorylated tau directly impede transport (Patrick et al., 
1999; Seitz et al., 2002), particularly that of anterograde-directed axonal cargo (LaPointe 
et al., 2009). Amyloid plaques also slow transport (Pigino et al., 2009). Alzheimer’s-
associated transport disruption has been specifically demonstrated for mitochondria, 
endosomes, multivesicular bodies, synaptophysin, syntaxin, and TrK endosomes 
(Lazarov et al., 2007; Pigino et al., 2003). These transport defects contribute to the 
overall pathology and pathogenesis of the disease.  
In addition to deficits in axonal transport, AD is associated with dysregulated 
CDK5 activation. Post-mortem brains from patients with Alzheimer’s disease exhibit 
significantly higher CDK5 levels than those of controls, and p25 expression increases 
with disease progression (Lee et al., 1999; Patrick et al., 1999). One potential cause is 
pathologic Aβ, which increases p25 production in neurons. As a result, Aβ injection into 
mammalian brains causes hyperphosphorylation of the CDK5 substrate tau, 
synaptotoxicity, and neuronal death (Lopes et al., 2010). Induction of p25 expression, 
without other genetic modifications results in an Alzheimer’s-like phenotype, including 
atrophy of the brain and formation of neuritic tangles (Cruz et al., 2003). Not only does 
Aβ lead to production of p25, but p25/CDK5 in turn causes increased Aβ formation, 
creating a cyclical path which results in further neurodegeneration (Wen et al., 2008). 
CDK5 activated by p25 also aberrantly phosphorylates neurofilaments, causing further 
pathology (Maccioni et al., 2001). Taken together, increased CDK5 activity is associated 
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with memory loss and neurofibrillary tangles (Li et al., 2014), fragmentation of Golgi 
bodies (Sun et al., 2008), and formation of Aβ plaques (Cruz et al., 2006).  
 
Motor Neuron and Peripheral Neuron Diseases 
Multiple motor neuron diseases exhibit changes in axonal transport that result in 
neuronal dysfunction and eventual neuron death. Spinal muscular atrophy, which is 
characterized by progressive weakness, can be caused by mutations in dynein (Harms 
et al., 2012). Additionally, disrupted transport has been observed in human patients with 
motor neuron disease (Hafezparast et al., 2003) and in mouse models of disease (Puls 
et al., 2003), even when no dynein or kinesin mutation was present. These diseases 
also demonstrate increased CDK5-dependent phosphorylation of neurofilaments, 
resulting in decreased anterograde transport of the affected components (Holmgren et 
al., 2013). 
Defects in axonal transport are particularly prevalent in amyotrophic lateral 
sclerosis (ALS). The pathogenesis of ALS involves early-onset disruption of axonal 
transport (Collard et al., 1995; Roy et al., 2005; De Vos et al., 2007; Warita et al., 1999; 
Williamson and Cleveland, 1999). Mutations in the dynein cofactor dynactin are a direct 
risk factor for ALS (Stockmann et al., 2013), while mutations in kinesin-associated 
proteins can increase survival in ALS (Landers et al., 2009). CDK5 has also been 
strongly implicated in pathology of the disease (Redler and Dokholyan, 2012). In mouse 
models of ALS, similar to what has been observed in AD, highly active CDK5 
hyperphosphorylates both tau and neurofilaments (Nguyen et al., 2001), resulting in 
reduced transport. 
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Charcot-Marie Tooth (CMT), a disease of peripheral motor and sensory nerves, 
can also be caused by a mutation in the heavy chain of dynein (Weedon et al., 2011). 
CMT is characterized by muscle weakness and atrophy, as well as loss of touch 
sensation. CDK5 activity is increased in a CMT cell culture model, with corresponding 
decreased transport and increased phosphorylation of neurofilaments. 
 
Huntington’s Disease 
In HD, defects in axonal transport precede cell death (Li and Li, 2004). The primary 
cause of HD is the proliferation poly-glutamine (polyQ) repeats in the huntingtin protein, 
which results in formation of neuronal aggregates and eventual cell death. In various 
diseases associated with polyQ repeats, including HD, neurons exhibit reduced axonal 
transport due to proliferation of these pathogenic proteins (Gunawardena et al., 2003; 
Her and Goldstein, 2008; Szebenyi et al., 2003). PolyQ-huntingtin has also been 
demonstrated to directly inhibit axonal transport in neurons (Szebenyi et al., 2003). 
Multiple aspects of axonal transport have been queried, and all were found to be 
disrupted with expression of polyQ-huntingtin (Dompierre et al., 2007; Engelender et al., 
1997; Gauthier et al., 2004; McGuire et al., 2006; Morfini et al., 2009). Intriguing, high 
levels of CDK5 activity in HD appear to be partially neuroprotective, as p25/CDK5 
decreases the formation and maintenance of huntingin aggregates (Anne et al., 2007; 
Luo et al., 2005). However, CDK5 also mediates dopamine and glutamate toxicity 
(Paoletti et al., 2008), indicating that the role of CDK5 in HD is more complicated than in 
other neurodegenerative diseases. 
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Parkinson’s Disease 
The ties between PD and defects in axonal transport are more tenuous. Alpha-synuclein, 
one of the proteins strongly implicated in the pathogenesis of PD, causes defects in 
anterograde and retrograde axonal transport (Saha et al., 2004). In contrast, CDK5 
activation has been clearly linked to PD. CDK5 expression is increased in the Lewy 
bodies of patients with PD (Brion and Couck, 1995). Further, CDK5 modulates synphilin-
1/α-synuclein inclusion formation through phosphorylation of Parkin (Avraham et al., 
2007). Although the transport phenotype is poorly understood, CDK5-mediated 
disruption of neuronal function is well documented in PD. 
 
1.5 Properties of Cultured Neurons 
Primary cultured neurons offer the best setting in which to assess axonal transport in 
healthy or diseased states. The mammalian body contains thousands of different types 
of neurons, many of which have been used in the pursuit of scientific discovery. Neurons 
are frequently cultured from rats and mice. The most common primary neurons used in 
laboratory culture are cortical, hippocampal, dorsal root ganglion, and motor neurons. 
Cortical, hippocampal, and motor neurons are isolated from the central nervous system 
(Saijilafu and Zhou, 2012; Wilcox et al., 1994). Sensory neurons, such as dorsal root 
ganglion neurons are located in the peripheral nervous system (Kandel et al., 2000). 
 
Neuronal Compartments and Location 
Dorsal root ganglion neurons (DRGs) are perhaps the easiest neurons to culture from 
rats and mice (Melli and Höke, 2009), and as such have been used extensively (Klinman 
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and Holzbaur, 2015; Maday et al., 2012; Moughamian et al., 2013). The cell bodies of 
DRG neurons reside in the dorsal root ganglion, bilateral pouches outside the spinal 
cord that abut each vertebral body (Kandel et al., 2000). Peripheral neurons contain 
molecular machinery that permits re-growth of injured processes. As a result, DRG 
neurons extend long neurites after 1-2 days in culture (Klinman and Holzbaur, 2015; 
Pandey and Smith, 2011; Saijilafu and Zhou, 2012).  
DRG neurons are pseudo-unipolar, and thus contain one bifurcated axon and no 
dendrites in situ. The two ends of the split axon are termed the distal process, whose 
terminal synapses are located in the skin, and the proximal process, whose terminal end 
synapses in the posterior horn of the spinal cord (Kandel et al., 2000). Sensory 
information from afferent DRG neurons is relayed from the distal process to the proximal 
process. The axon of DRG neurons is capable of initiating an action potential from the 
distal end and propagating it towards the proximal end, without interference from the cell 
soma. Different classes of DRG neurons carry different types of sensory information, 
ranging from soft touch to vibration (Kandel et al., 2000; Melli and Höke, 2009). 
In contrast, hippocampal neurons are isolated from the hippocampus of mice and 
rats. As such, isolation involves direct dissection of the brain, and separation of the 
hippocampal region from the rest of the brain parenchyma (Kaech and Banker, 2006). 
Hippocampal neurons are CNS neurons, and thus cannot be cultured from an adult 
animal. As a result, embryonic tissue is required. Unlike DRG neurons, hippocampal 
neurons grow polarized processes rather than undifferentiable neurites. By 5 days in 
vitro (DIV) cultured primary hippocampal neurons exhibit clear discrimination between 
dendrites and axons (Dotti et al., 1988). Dendrites tend to have a larger radius, branch 
readily, and exhibit mixed-polarity microtubules (See Section 1.2), among other features 
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(Baas et al., 1988; Dotti et al., 1988; Petersen et al., 2014). They act as the inputs into 
the neuron. In contrast, axons are narrow and extend very long processes that branch 
rarely (Baas et al., 1988). A given hippocampal neuron will have multiple dendrites, and 
typically only one axon (Dotti et al., 1988). The axon is identified though a distinct region 
between the proximal axon and the soma known as the axon initial segment (AIS), and 
exhibits a parallel array of plus-end-out oriented microtubules (See Section 1.2) (van 
Beuningen et al., 2015). This increased complexity in hippocampal neurons makes them 
ideal for studying aspects of targeting, directed transport, and signaling.  
 
Sorting and Transport 
In dissociated culture, DRG neurons grow multiple processes, referred to as neurites 
(Klinman and Holzbaur, 2015). These processes share many characteristics of axons, 
although they do not have the cytoskeletal machinery required to set up a dedicated 
axon initial segment, as do hippocampal neurons. At 2 days in vitro (DIV), the neuritic 
arbor of DRG neurons can extend up to at least 8,000 microns (personal communication 
from A. Stavoe). The sweeping arcs of neurite are ideal for imaging mid-axonal 
transport, while actively evolving tips at the end of a lengthening neurite are amenable to 
growth cone analysis (Jun et al., 2015; Sayyad et al., 2016). As DRG neurons are 
peripheral neurons, they are capable of re-growing their axons in vivo and in culture 
which permits study of neurite regeneration. 
Unlike DRG neurons, hippocampal neurons grow multiple distinct processes 
making them ideal for the study of sorting (Petersen et al., 2014). The regulatory 
machinery that governs processing of proteins, cargos, and organelles into the axon, 
soma, or dendrite can easily be examined in these neurons (Kuijpers et al., 2016; 
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Maeder et al., 2014). However, hippocampal neurons require sustained culturing for five 
days or more to achieve maturity and functional separation of axon from dendrites (Dotti 
et al., 1988). Within 7-8 days, hippocampal neurons grow long axons and a multitude of 
shorter dendrites (Dotti et al., 1988). At this point, a distinct AIS has formed, which can 
be used to identify the start of the proximal axon based on the location of Ankyrin G, 
voltage-gated sodium channels, and other AIS-specific proteins (Hedstrom et al., 2008; 
Winckler et al., 1999). Hippocampal neurons have been used extensively to study the 
differences between axonal and dendritic transport, often using the somatodendritic 
transferrin receptor (Petersen et al., 2014; Song et al., 2009).  
 
Neuronal Age 
DRG neurons are unusual among primary neurons in that they can be isolated and 
cultured from adult animals, in addition to young and embryonic animals (Melli and 
Höke, 2009; Saijilafu and Zhou, 2012). This distinctive feature makes them useful for 
studying adult-onset diseases and changes associated with old age and aging (Bilsland 
et al., 2010; Perlson et al., 2009). Many, though not all, of the changes associated with 
aging can be seen in cultured neurons from older mice (Bilsland et al., 2010; Perlson et 
al., 2009). Diseases associated with old age, such as PD, AD, and ALS, are best studied 
in older animals (Morfini et al., 2009). Fortunately, multiple mouse models exist for each 
of these diseases, and many disease-associated features can be observed in peripheral 
neurons. Moreover, a single adult mouse provides enough DRG neurons for multiple 
experiments. As a result, DRG neurons have become a key model for studying adult-
onset conditions and diseases. 
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Hippocampal neurons, on the other hand, must be isolated from embryonic 
animals. Neurons taken from the central nervous system only grow robustly in culture 
when procured from animals in which neurogenesis is ongoing (Kaech and Banker, 
2006). This makes it difficult to study adult-onset diseases, as many neurodegenerative 
diseases require buildup of toxic byproducts over time. However, hippocampal neurons 
are a good model to study neurodevelopment and maintenance of required systems and 
proteins (Ghiretti and Paradis, 2011; Hedstrom et al., 2008; Ma et al., 2010). 
Hippocampal neurons from strains of mice and rats with embryonic-lethal mutations 
have been used to identify the involved proteins and results of mutations of these 
proteins in still-developing neurons (Chae et al., 1997; Magen et al., 2015; Yamada et 
al., 2009). Thus, DRG neurons and hippocampal neurons provide complimentary 
approaches to assay neuronal maintenance and development. 
 
1.6 Regulation of Dynein by CDK5 in Different Neuronal Compartments 
This work focuses on the role of CDK5 in controlling mid-axonal cargo transport as well 
as sorting at the axon initial segment. We address the results of p25-induced CDK5 
activation in the mid-axon of DRG neurons and the resulting disruption of transport. We 
then assess the mechanism of the observed transport changes and determine that the 
resulting system can be manipulated to rescue transport defects in peripheral neurons 
from an ALS model mouse. We next explore the function of CDK5 in the AIS of 
hippocampal neurons and determine if the mechanism by which CDK5 affects cargo 
motility is the same as that observed in the mid-axon. Finally, we establish which 
cytoskeletal changes are associated with changes in CDK5 activity, and the effect this 
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has on neuronal function. Overall, these studies show that CDK5 is required for multiple 
aspects of axonal structure and function.  
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2.1 Abstract  
Axonal transport is important for neuronal development and the maintenance of effective 
neuronal function in mature cells. Observing the active transport of organelles and 
vesicles along the axons of living neurons has emerged as a valuable tool for probing 
the health of the neuron, and assessing changes associated with stress and 
neurodegenerative disease. Transport relies on two families of motor proteins: kinesins 
and dynein. Using these motors, a diverse set of cargos are transported toward the axon 
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tip, the cell body, or anywhere in between. Of particular interest are organelles and 
cargos associated with disease and the changes in motility that these cargos undergo 
during pathogenesis. Here, we describe the factors that should be considered when 
studying different cargos, and the imaging parameters associated with optimal tracking 
of various organelles and proteins. Ultimately, the ideal cargo to investigate depends on 
the question being asked and the limitations of individual microscopes available for 
imaging.  
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2.2 Introduction 
Advances in imaging technology and cell culture have broadened the range of questions 
that can be probed using microscopy. Microscopes capable of capturing repetitive high-
resolution images acquired at fast frame rates, coupled with live-cell media and 
chambers to maintain healthy cells over longer periods of time, have made it possible to 
image the motion of various cargos as they move throughout the axon in cultured 
neurons. As a result, observing axonal transport in living neurons has emerged as a 
valuable tool both for probing the health of a neuron and for assessing neuronal changes 
associated with stress and disease (M’Barek et al., 2013; Perlson et al., 2009).  
Neurons are difficult to maintain in culture; they require long growth periods, 
suitable growth media, fastidious temperature control, and proper cell density to thrive. 
This combination makes imaging neurons challenging. However, unlike more easily 
cultured cells, neurons maintain a clear differentiation between distinct subcellular 
domains, namely, the axon and the dendrites. Moreover, as the biosynthetic machinery 
is also generally compartmentalized, vast distance must be covered to deliver newly 
synthesized organelles or proteins to the distal ends of axons or dendrites. These 
features make neurons an ideal model for studying intracellular transport, despite the 
challenges of culturing neuronal cells.  
Before beginning a project, it is important to consider which aspects of cellular 
transport one will be analyzing, and thus which cells to culture. Neurons cultured from 
dorsal root ganglia (DRG) of mice or rats are possibly the easiest and fastest to grow, as 
these neurons extend axons >1 mm over 2e4 days in culture (Maday et al., 2012). 
Moreover, these cells can be isolated from adult mice or rats, making them valuable in 
the study of late-onset diseases or for the analysis of the long-term effects of drug 
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treatment (Zhu and Sheng, 2011). However, DRG cells only grow axons, not dendrites. 
This makes them ideal candidates for studying long-range axonal transport, but not 
useful for examining differential targeting of cargos into axons versus dendrites. DRG 
neurons also necessitate additional lab equipment for expression of exogenous DNA, as 
they respond best to electroporation rather than simple chemical transfection for efficient 
and robust protein expression.  
In contrast, hippocampal and cortical neurons grow both an axon and dendrites, 
but are more difficult to culture (Ghiretti and Paradis, 2011; Kaech and Banker, 2006). 
Hippocampal and cortical neurons usually require multiple days or even weeks of in vitro 
culture prior to imaging (Dotti et al., 1988). However, they are relatively easy to 
chemically transfect and can provide data on active transport in both axons and 
dendrites. Hippocampal culture yields fewer cells per animal sacrificed, but the cells are 
more uniform. In contrast, a cortical culture is a mixture of several types of neurons, but 
a higher number of cells can be obtained per animal. Other neuronal types, such as 
motor neurons, require more specific removal and purification steps for isolation and 
growth in order to produce a culture that is not overly contaminated by non-neuronal 
cells (Fallini et al., 2010) (Figure 2.1). Finally, most types of neuronal culture, other than 
DRGs, must be isolated from embryonic animals.  
The most critical aspect to acquiring useful data on neuronal transport comes 
from selecting the proper cargo and determining the most effective imaging parameters. 
Using a cargo that does not reflect the question or recording at inappropriate time 
intervals can result in misleading or missed data. A broad overview of selection criteria 
and imaging parameters for individual cargos in neuronal axons are presented below.  
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2.3 Selection of Cargo  
Before any decisions are made as to the assessment of transport dynamics of various 
cargos, it is important to keep in mind the questions being asked and approach cargo 
selection within the relevant bounds. If a particular disease is being studied, make sure 
to examine cargos known to be affected in the disease rather than only looking at ones 
which would be easy to image. If the project focuses heavily on one type of motor 
protein, limit analysis to cargos transported by that protein. Ideally, multiple potential 
cargos will be identified that would be of interest to a given project. Once a list of 
possible cargos has been made, it is time to pick and choose from among them to select 
for such things as ease of imaging and analysis. 
 
Figure 2.1 DRG and 
hippocampal neurites 
Neurites extending from 
dorsal root ganglia (DRG) 
(top) and hippocampal 
(bottom) neurons 
expressing lysosomal 
marker LAMP1-RFP. 
Higher magnification of 
the boxed region of each 
axon is shown to the right 
of the image in black and 
white. 
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2.3.1 Properties of Cargo Motion 
When deciding what cargo to image, a few key factors must be discussed:  
• Does the cargo studied move quickly or slowly?  
• Is the cargo one that densely populates the axon or is it only sparsely localized  
throughout the axon?  
• Is the cargo highly motile or mostly stationary?  
• Does the process under study affect anterograde-directed, retrograde-directed, 
or  
• bidirectional cargos? 
Each of these considerations will be addressed below.  
 
2.3.2 Velocity 
One of the first questions to address when assessing how to image a cargo is how 
quickly the cargo is moving. Recording the motion of a slowly moving cargo is ideal, as 
individual cargo will be easy to track, and frames can be acquired at larger intervals 
without losing resolution. Conversely, imaging cargos that move quickly will produce 
large amounts of data over a shorter period of time.  
The velocity with which the cargo moves will determine the frame rate, and 
subsequently the likelihood of cargo bleaching over the course of imaging. Imaging 
slowly moving cargo causes less stress on both the researcher and the microscope. 
Fast moving cargo requires a high frame rate, thus increasing exposure of the axon to 
intense light and raising the probability that the cargo will bleach. High-velocity cargo 
imaged at a low frame rate results in an inability to clearly follow the path of the 
individual cargo.  
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The speed of transport of a particular cargo is dependent on the motor proteins 
driving its motility, as well as the overall processivity of the cargo. Depending on which 
motor protein is of interest, cargo can be selected based on known transport speeds in 
an attempt to focus on the function of one motor over another.  
 
2.3.3 Density 
Another important consideration when designing a live-cell imaging experiment is the 
density of cargos in the axon of primary neurons. Some cargos populate the axon to 
such an extent that it is difficult to distinguish individual tracks in a kymograph; others 
move too infrequently to image efficiently within a single frame. Most cargos fall between 
these two extremes. There is a high probability of catching at least one if not many 
motile events over the imaging period with these intermediate cargos. Similarly, each 
cargo is separated sufficiently in space and time such that deter- mining their 
parameters of motility is straightforward. For each type of cargo, there is a balance 
between collecting enough data - easier with high-density cargo - and collecting distinct 
runs of motion - easier with sparse cargo (Figure 2.2).  
Another aspect of cargo analysis that is affected by density is the fragmentation 
or fusion of individual cargo, such as mitochondria and degradative organelles (Ashrafi 
et al., 2014). The unambiguous identification of fission or fusion events is easier for 
cargos at lower densities along the axon.  
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Figure 2.2 Cargo density: LC3 and LAMP1 
Cargos with low density, such as autophagosomes (LC3 - top), are easier to track but 
provide less data per neuron than cargos with high density, such as lysosomes (LAMP1 
- bottom). Cargo indicated in black; axon in gray. Arrows indicate sparsely distributed 
autophagosomes.  
 
2.3.4 Motility  
Cargos actively moving along the axon can be roughly divided into four categories: 
anterograde (toward the axon terminal), retrograde (toward the cell body), bidirectional, 
or stationary. Bidirectional cargos can either move robustly in both the anterograde and 
retrograde directions or display saltatory stop-and-start motility that is often binned with 
stationary cargo. Even if a cargo moves primarily in a single direction, both kinesin and 
dynein motors are likely to be bound (Encalada and Goldstein, 2014; Fu and Holzbaur, 
2014; Maday et al., 2012; Welte, 2004), and thus the cargo may be capable of moving 
bidirectionally as well. Stationary cargos show minimal motility. For most cargos, 
however, there will be a fraction that remains stationary throughout the duration of 
imaging, independent of the overall active motility of the cargo.  
It is also important to keep in mind that motility is variable - even stationary 
cargos are likely to move if the imaging time span is sufficiently long. Moreover, 
appropriately binning cargo into anterograde, retrograde, stationary, or bidirectional 
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requires an understanding of the dynamics of specific cargo. Slow-moving cargo will 
take longer to reach a prescribed cutoff for motion than faster moving cargo, and thus 
the same criteria cannot be applied across all cargos without changing the imaging 
parameters such as frame rate or movie duration.  
 
2.4 Basics of Imaging  
On the day of imaging, cells should be switched from normal culture media to imaging 
media, such as Hibernate A supplemented with B27 and GlutaMAX (Maday et al., 2012). 
Care should be taken to avoid displacing the neurons from their attachment to the plate. 
This is best done by removing media slowly using a P1000 pipette, and replacing media 
slowly at the edge of the dish, letting it fill the plate naturally (fill the rim before the glass 
bottom).  
The glass-bottomed imaging dish should be placed in the microscope, which 
must be equipped with a live-cell chamber. Recommended viewing is 60-100x, with an 
oil-immersion lens. Once situated, it is easiest to focus on the specimen using bright-
field light, prior to switching to laser fluorescence. For DRG neurons, transfection 
efficiency by electroporation is between 30% and 45%, so transfected cells should be 
easy to find. Transfection efficiency in cortical and hippocampal cells is between 20% 
and 30% using Lipofectamine 2000 d(Dalby et al., 2004).  
Once a cell is identified, focus such that individual cargo puncta are clearly 
differentiable in the imaging software. Attempt to adjust the exposure, gain, and intensity 
of the laser only once, such that all cargos of one type are recorded with the same 
parameters. If the parameters need to be changed for a particular cell, make sure to 
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record these changes. Ideal cells should show readily visible fluorescence, but should 
not be so bright as to make distinguishing between the cytoplasm and the cargo difficult.  
After recording from the axon of the transfected cell, make sure to note in which direction 
the cell body lies and the approximate distance from both the cell body and the axon 
terminal where the imaging field was recorded. Meanwhile, minimize exposure of the 
cells to light, particularly from the laser, whenever possible.  
Do not attempt to record for more than an hour; prolonged laser exposure kills 
the cells. 5-6 cells per culture dish are sufficient for analysis, with data from 3 different 
animals for a total of 15-18 cells.  
 
2.5 Analysis of Transport  
Once cargo has been chosen and imaged, it is essential to properly analyze the cargo to 
extract the relevant data. Examine the data for any changes between conditions that are 
readily observable. Does transport diminish? Is the velocity or density changed? Does 
the motility appear different (more retrograde or anterograde than normal, more switches 
in directed runs, fewer pauses during active transport)? Based on these observations, 
quantification can begin. Independent of the chosen method of analysis, it is useful to 
know the average velocity of your cargo, the overall density of the cargo, and the 
percent motility by direction. Once these values are extracted, choosing the relevant 
features of motion can be simplified.  
To turn the movie into a 2D image that can be readily analyzed, a kymograph 
should be created. A kymograph is an image that represents motion (distance, x-axis) 
over time (y-axis), wherein the path of the axon is traced and straightened, and the 
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intensity along the selected neurite is plotted for all the images from a movie. 
Kymographs can be generated using many types of image analysis software, including 
ImageJ (provided for free by the NIH). To make a kymograph for analysis, download an 
ImageJ plugin (such as kymograph from embl.de/eamnet/html/body_kymograph.html) 
and follow the instructions provided (embl.de/eamnet/downloads/kymograph/kymograph 
_description.pdf). Other software such as Volocity (Perkin Elmer) and MetaMorph 
(Molecular Devices) are also capable of generating kymographs.  
 
2.6 Axonal Cargos Demonstrate Distinct Patterns of Motility  
We will discuss how to label and image a range of cargos, including late endosomes, 
lysosomes, and autophagosomes, as well as signaling endosomes, mitochondria, and 
the disease-associated amyloid precursor protein (APP). Each cargo described displays 
unique characteristics of velocity, density, and run length.  
Each cargo covered in this section is labeled via transfection of a fluorescently 
labeled protein and thus relies on exogenous DNA expression. There also exist vital 
dyes capable of staining endogenous organelles (Zhang et al., 2009). These dyes 
highlight the appropriate organelle in all cells in the culture dish, rather than the more 
limited labeling usually obtained by transfection with either electroporation or lipofection. 
While vital dyes lead to an increase in the number of possible organelles for analysis, 
labeling of the entire plate makes it very difficult to trace back an individual axon or 
dendrite to its cell body, and thus to unambiguously determine the polarity of the 
process. However, this issue can be overcome by growing neurons in polarized 
microfluidic chambers (Taylor et al., 2010).  
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Both lysosomes and mitochondria can be imaged using the vital dyes 
LysoTracker and MitoTracker, respectively (Liu et al., 2007; Pandey and Smith, 2011; 
Zhu and Sheng, 2011). It is important to note that these dyes bleach more rapidly than 
exogenously expressed fluorescently tagged constructs. Further, many organelles do 
not take up the dye effectively and can be misidentified; for example, LysoTracker often 
identifies autophagosomes in addition to lysosomes (Maday et al., 2012). Given these 
shortfalls, the focus of this chapter will be on exogenously expressed tagged cargos.  
 
2.6.1 Late endosomes/lysosomes – Rab7 (Figure 2.3) 
Velocity 
Rab7-positive late endosomes move quickly along axons, at instantaneous velocities of 
up to ~1.2 µm/s (Deinhardt et al., 2006). In order to observe the full range of dynamic 
motility, the camera must be able to capture three frames per second. This frame rate is 
high enough to identify most changes in direction or speed during transport. One minute 
of imaging per field is usually sufficient to collect ample data, due to the robust motility of 
Rab7-positive organelles.  
Density 
Rab7 is a medium-to-high-density cargo in the axon (approximately 30 vesicles per 100 
µm). It is dense enough to make identification of individual cargo difficult, but possible. 
Overall, most runs of motion can be distinctly identified.  
Motility 
Rab7-positive endosomes have a tendency to move in the retrograde direction, although 
bidirectional transport is clearly visible in movies. The overall breakdown of Rab7 motility 
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in axons is roughly 6% anterograde, 16% retrograde, and 78% stationary (defined as 
having moved <10 µm over 1 minute) in our hands (Figure 2.3). This makes Rab7 a 
good marker for kinesin-driven motility and great marker for dynein-driven motility 
(Deinhardt et al., 2006; Maday et al., 2014).  
 
Figure 2.3 Late endosomes/lysosomes – Rab7 
Late endosome/lysosome motion in dorsal root ganglia neurites expressing GFP-Rab7. 
Late endosomes can be found along all neurites in a transfected cell. The kymograph 
(bottom) displays robust motility; anterograde motion is down and to the right; scale bar 
indicates 10 s and 10 µm. Bar graphs display overall percent motile versus stationary 
cargo, and a breakdown of the motile fraction into anterograde- and retrograde-directed 
events. This convention will be held for all subsequent figures.  
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2.6.2 Late endosomes/lysosomes – LAMP1 (Figure 2.4)  
Velocity 
Lysosomes move quickly, approximately 1.2 µm/s (Moughamian and Holzbaur, 2012). 
An imaging speed of three frames per second or higher is recommended to capture the 
full range of motion, similar to Rab7. This speed allows the user to track individual cargo. 
No more than 1 min of imaging is required to capture the range of motion of lysosomes.  
Density 
LAMP1-positive lysosomes are a high-density (>50 vesicles/100 µm) cargo. They make 
an ideal candidate for study in experiments comparing drug treatment or transfection 
conditions that are expected to change the ensemble velocity of transport; changes in 
the overall motion of the cargo will be easily identified due to their density (Moughamian 
and Holzbaur, 2012). However, this high density makes distinguishing between 
individual organelles difficult, and it might be impractical to track each cargo in the 
imaging field. To avoid this, one can select a smaller number of cargos that meet certain 
criteria from each neuron to analyze (i.e., fastest moving, fewest pauses, most distance 
covered).  
Motility 
Lysosomes are highly bidirectional. They display little bias for anterograde (19%) versus 
retrograde (19%) transport and have a middling probability (62%) of moving less than 10 
µm during an imaging session of 1 min (Figure 2.4). Both kinesin and dynein motor 
activity can be studied by analyzing lysosomal motility (Maday et al., 2014; Moughamian 
and Holzbaur, 2012).  
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Figure 2.4 Late endosomes/lysosomes – LAMP1 
Lysosome motion in dorsal root ganglia neurites expressing LAMP1-RFP. Lysosomes 
can be found in all along neurites in transfected cells. The kymograph (bottom) shows 
very high motility. Anterograde motion is down and to the right; scale bar indicates 10 s 
and 10 mm.  
 
2.6.3 Autophagosomes – LC3 (Figure 2.5)  
Velocity 
Autophagosomes require a different set of imaging parameters than lysosomes or 
endosomes. They move far slower (~0.45 µm/s) than lysosomes and endosomes, and 
thus are ideal for situations requiring imaging over a long period of time (Maday et al., 
2012). One frame every 3 s is sufficient to observe autophagosome dynamics, and 
imaging can proceed for 3-5 min without noticeable bleaching (Maday et al., 2012).  
Density 
Autophagosomes are sparse along the axon (approximately 3 per 100 µm). Care should 
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be taken when selecting an axon for imaging, as not all axons have autophagosomes 
present. As a result, however, it is very easy to track the motion of an individual 
autophagosome, as there are seldom others nearby. The kymograph below is unusual 
for the number of autophagosomes present, although their behavior is typical.  
Motility 
Motile LC3-positive autophagosomes move almost exclusively in the retrograde direction 
(55%). Less than 1% of autophagosomes move toward the axon terminal, with the 
residual 44% remaining stationary (Figure 2.5). Autophagosomes rely on dynein-driven 
motility; although kinesin is present on the cargo, it is in an inactive state (Maday et al., 
2012).  
Figure 2.5 Autophagosomes – LC3  
Autophagosome motion in dorsal root ganglia neurites expressing GFP-LC3. Kymograph 
displays typical retrograde-biased transport, although the number of autophagosomes 
per neuron is typically lower than displayed. Anterograde motion is down and to the 
right; scale bar indicates 20 s and 10 µm. Bar graphs indicate the high levels of motile - 
particularly retrograde - autophagosomes.  
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2.6.4 Mitochondria – MITO (Figure 2.6)  
Velocity 
Mitochondria move at varying speeds, from very fast (high frame rate required) to very 
slow (similar to autophagosomes) (Hollenbeck and Saxton, 2005). The imaging speed 
will depend on which type of motility is relevant for a particular experiment. As a rule of 
thumb, the larger the individual mitochondrion, the slower it moves, assuming it is motile 
(Chen and Chan, 2009). A low frame rate, such as one frame every 3 s, is sufficient to 
capture most of the dynamic motion of mitochondria. Of note, a faster frame rate (three 
frames per second) is recommended if the goal is to observe mitochondrial fragments 
within autophagosomes. Mitochondria are best imaged for 3 min.  
Density 
The density of mitochondria along the axon varies by cellular health. Normal healthy 
neurons have a middling number of mitochondria in a given axon (approximately 28 per 
100 µm), with a mix of small highly motile organelles and larger less motile organelles. 
However, cellular stress causes mitochondrial fission (Chen and Chan, 2009). If the 
experiment requires working with drugs that can injure the cell, the mitochondria in the 
axon will appear smaller. These fragments will likely display the higher speeds typical of 
smaller mitochondria, which can make them difficult to track. In healthy cells, 
mitochondria are an excellent initial cargo for tracking axonal transport, as enough are 
present in any given neurite to obtain data, but the numbers are low enough to not be 
overwhelming (as can occur with lysosomes).  
Motility 
Mitochondria are roughly split between anterograde (13%) and retrograde (15%) motile 
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events, with the remaining (71%) moving less than 10 µm over 3 min of imaging (Figure 
2.6). Mitochondria can also be observed to split and fuse (fission and fusion) over the 
course of imaging, with more fission occurring during stressful conditions.  
Figure 2.6 Mitochondria – MITO  
Mitochondria are readily visible in dorsal root ganglia neurites expressing DsRed2-mito. 
Kymograph of mitochondrial motion (bottom) shows many motile events as well as many 
nonmotile puncta. Anterograde motion is down and to the right; scale bar indicates 20 s 
and 10 µm.  
 
2.6.5 Signaling endosomes – TrkB (Figure 2.7)  
Velocity 
Signaling endosomes move quickly, but not as quickly as lysosomes, averaging speeds 
between 0.2 and 3 µm/s (Maday et al., 2014). However, they are very small cargos and 
tend to bleach more rapidly than the other cargos discussed here. In order to capture the 
range of movement of signaling endosomes, a frame rate of two frames per second is 
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recommended. However, over the course of a 2-min movie, expect to see some loss of 
signal due to cargo bleaching.  
Density 
TrkB-positive signaling endosomes are of medium density in the axon (approximately 30 
vesicles per 100 µm). There are few enough to make them reasonably easy to track, but 
it is still possible to lose some. This is due to the type of motility displayed by signaling 
endosomes (see below) as well as the propensity of the fluorophore to bleach.  
Motility 
The motility of signaling endosomes is complicated; depending on the conditions within 
the culture dish, they behave differently. In culture media without any additional factors, 
they move rapidly both anterograde (17%) and retrograde (23%), with approximately 
60% of puncta moving less than 10 µm (Figure 2.7). However, even when actively 
moving in one direction, their motion is frequently interrupted by pauses and directional 
reversals, making them somewhat difficult to track. When exposed to a stimulating agent 
(the signaling factor brain-derived neurotrophic factor (BDNF) in the case of TrkB, and 
nerve growth factor (NGF) in the case of TrkA (Maday et al., 2014)), the motility changes 
dramatically. In this situation, almost all of the motility is in the retrograde direction, 
bringing the signaling endosome and its endocytosed signal to the cell soma (Maday et 
al., 2014). This would be an ideal mechanism by which to study robust dynein motility.  
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Figure 2.7 Signaling endosomes – TrkB  
Neurons expressing TrkB-mRFP exhibit signaling endosomes in their neurites, but the 
signal is not as strong as for other cargos and tags. Kymograph of signaling endosome 
motion in unstimulated cells shows bidirectional motility with pronounced bleaching over 
the course of 2 min. Anterograde motion is down and to the right; scale bar indicates 10 
s and 10 µm.  
 
2.6.6 Amyloid precursor protein – APP (Figure 2.8)  
Velocity 
APP moves very quickly at up to ~2 µm/s (Fu and Holzbaur, 2013). Of all the potential 
cargos covered in this section, APP requires the fastest rate of imaging. In order to 
capture the motion of APP and ensure proper identification of an individual cargo, the 
protein should be imaged at four frames per second. Only 1 min of imaging is sufficient 
to reveal active motility.  
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Density 
APP is a high-density protein in the neurites of dorsal root ganglion neurons 
(approximately 80 vesicles per 100 µm (Fu and Holzbaur, 2013)). This occasionally 
makes the cargo difficult to track. However, many of the individual cargos move at the 
same velocity, creating easy-to-follow parallel lines, despite the high cargo density.  
Figure 2.8 Amyloid precursor protein – APP  
Amyloid precursor protein (APP) is readily visible in the neurites of dorsal root ganglia 
neurons expressing APP-YFP. The kymograph exhibits robust anterograde motility. 
Anterograde motion is down and to the right; scale bar indicates 10 s and 10 µm.  
 
Motility 
APP is a primarily anterograde-directed cargo. Although APP is capable of bidirectional 
transport, it is the only cargo covered in this section that relies more heavily on kinesin 
than dynein for motility in the axon. Approximately 29% of motion is in the anterograde 
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direction, while only 7% of APP puncta move predominately retrograde (Figure 2.8). The 
residual 64% are stationary over 1 min of imaging.  
 
2.7 Conclusion 
Imaging axonal transport in primary neurons has proven to be a powerful tool to 
understand the mechanisms of intracellular trafficking required to maintain neuronal 
homeostasis. It has also proven useful as a method to probe the defects in transport 
associated with neurodegenerative disease. Determining the optimal imaging 
parameters for each cargo can be difficult, and careful consideration is required in order 
to generate appropriate conclusions about changes in axonal transport. The guidelines 
above will aid in the selection of suitable cargo to track in a given experiment, and help 
identify the particular motility characteristics of that cargo for satisfactory imaging and 
analysis.  
 
 
 
45 
 
CHAPTER 3 
Stress-Induced CDK5 Activation Disrupts Axonal 
Transport via Lis1/Ndel1/Dynein 
 
 
Eva Klinman & Erika L.F. Holzbaur (2015). Cell Reports 12, 462–473. 
doi:10.1016/j.celrep.2015.06.032 
 
 
3.1 Abstract 
Axonal transport is essential for neuronal function, and defects in transport are 
associated with multiple neurodegenerative diseases. Aberrant cyclin dependent kinase 
5 (CDK5) activity, driven by the stress-induced activator p25, is also observed in these 
diseases. Here, we show that elevated CDK5 activity increases the frequency of 
nonprocessive events for a range of organelles including lysosomes, autophagosomes, 
mitochondria, and signaling endosomes. Transport disruption induced by aberrant CDK5 
activation depends on the Lis1/Ndel1 complex, which directly regulates dynein activity. 
CDK5 phosphorylation of Ndel1 favors a high affinity Lis1/Ndel/dynein complex that 
blocks the ATP-dependent release of dynein from microtubules, inhibiting processive 
motility of dynein-driven cargo. Similar transport defects observed in neurons from a 
mouse model of Amyotrophic Lateral Sclerosis are rescued by CDK5 inhibition. 
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Together, these studies identify CDK5 as a Lis1/Ndel1-dependent regulator of transport 
in stressed neurons, and suggest that dysregulated CDK5 activity contributes to the 
transport deficits observed during neurodegeneration. 
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3.2 Introduction 
Axonal transport is essential to maintain neuronal viability, yet the molecular 
mechanisms that regulate transport are not yet understood. The coordinated activities of 
anterograde-directed kinesins and retrograde-directed dynein motors drive transport in 
neurons. Motor activity is regulated by multiple mechanisms, leading to efficient long-
distance transport and the specific targeting of organelles to appropriate locations (Fu 
and Holzbaur, 2014; Hancock, 2014; Maday et al., 2014). 
 One kinase proposed to regulate axonal transport is cyclin-dependent kinase 5 
(CDK5) (Goodwin et al., 2012; Ou et al., 2010; Pandey and Smith, 2011). While most 
cyclin-dependent kinases regulate the cell cycle (Dhariwala and Rajadhyaksha, 2008), 
CDK5 expression is limited to post-mitotic cells including neurons (Tsai et al., 1993). The 
primary activator of neuronal CDK5 is p35. The CDK5/p35 complex is both temporally 
and spatially regulated; the active complex remains bound to the plasma membrane and 
is inactivated within 20 minutes via CDK5-dependent phosphorylation of p35 (Figure 
3.1A), which targets p35 for ubiquitination and proteosomal degradation (Dhavan and 
Tsai, 2001; Kusakawa et al., 2000; Patrick et al., 1998).  
The CDK5/p35 complex plays an important role in neuronal development and 
migration, but its function in mature neurons is less well understood (Modi et al., 2012; 
Su and Tsai, 2011). Multiple studies have implicated CDK5 in the regulation of vesicle 
and organelle trafficking, with conflicting conclusions. In C. elegans, CDK5 regulates 
axodendritic sorting (Goodwin et al., 2012; Ou et al., 2010). In mice, CDK5 has been 
proposed to regulate the anterograde transport of organelles through a pathway 
involving glycogen synthase kinase 3 and kinesin (Morel et al., 2010; Morfini et al., 
2004). Alternatively, CDK5 has been proposed to enhance the bidirectional transport of 
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lysosomes via a mechanism involving nuclear distribution protein nudE-like 1 (Ndel1), 
Lis1, and dynein (Pandey and Smith, 2011). Ndel1 and Lis1 have been studied 
extensively in the context of lissencephaly; they form a complex that binds to and 
regulates cytoplasmic dynein (Huang et al., 2012; Wynshaw-Boris, 2007). Ndel1 is a 
known CDK5 phosphorylation target, suggesting a potential mechanism for the effects of 
CDK5 on dynein-mediated axonal transport.  
Under conditions of cellular stress, including oxidative stress, ischemia, 
mitochondrial dysfunction, inflammation, or disease, CDK5 activity becomes 
misregulated. Calcium influx activates calpain, which cleaves p35 to a membrane-bound 
p10 subunit and a cytosolic p25 subunit (Figure 3.1A) (Su and Tsai, 2011; Zhang et al., 
2012). The p25 subunit retains the activation site for CDK5, but not the phosphorylation 
site necessary for ubiquitination and subsequent degradation. Thus, the p25/CDK5 
complex displays sustained activation that is both temporally and spatially deregulated 
(Dhariwala and Rajadhyaksha, 2008).  
The deregulation of CDK5 in stressed neurons suggests that aberrant CDK5 
activity may contribute to neurodegeneration (Dhariwala and Rajadhyaksha, 2008). Both 
abnormal cellular localization and hyper-activation of CDK5 has been observed in 
neurons of patients with Amyotrophic Lateral Sclerosis (ALS). This rise in CDK5 activity 
is accompanied by accumulation of cargo in the cell body and proximal axon of both 
motor and sensory neurons in mouse models of ALS (Cozzolino et al., 2012; Shukla et 
al., 2012). Diverse cargo including lysosomes, autophagosomes, mitochondria, and 
signaling molecules such as neurotrophic factors and receptors, exhibit altered axonal 
trafficking in the disease state (Cozzolino et al., 2012; Magrané et al., 2014; Perlson et 
al., 2009).  
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Here we investigate the role of CDK5 in the regulation of axonal transport. We 
find that CDK5 activity is not required to maintain constitutive transport of multiple 
cargos. However, elevated CDK5 activity leads to misregulation of all cargos examined. 
Activated CDK5 operates via the Lis1/Ndel1/dynein pathway, as the effects can be 
blocked by mutations that prevent the CDK5-dependent phosphorylation of Ndel1 or 
mutations in Lis1 that inhibit binding to dynein. Finally, we establish that the transport 
deficits observed in a mouse model of ALS mirror the effects induced by activation of 
CDK5, and can be rescued by CDK5 inhibition. Together, these observations indicate 
that stress-induced activation of CDK5 may contribute to the disruption of transport 
observed in ALS and potentially other neurodegenerative diseases such as Alzheimer’s 
and Parkinson’s, that exhibit dysregulated CDK5 activity. 
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3.3 Materials and Methods 
Reagents 
GFP-LC3 transgenic mice (Mizushima et al., 2004) were obtained from RIKEN. 
Transgenic mice overexpressing SOD1G93A [B6SJL-Tg(SOD*G93A)1Gur/J] were from 
Jackson Laboratory. Constructs include DsRed2-mito (T. Schwarz, Harvard Medical 
School, Boston, MA), LAMP1-RFP (Addgene), mRFP-TrkB (Addgene) and GFP-Rab7 
(Addgene). Plasmids encoding, Ndel1, Ndel1 -5, Lis1, Lis1-K147A, hCDK5, dnCDK5, 
and p25 were from D.S. Smith, University of South Carolina. dnCDK5 and p25 were 
recloned into a bicistronic BFP-expressing vector to identify transfected cells. siRNA 
against CDK5 (Thermo Scientific) was generated based on Xing et al. (2012). Antibodies 
include polyclonals to CDK5 (Santa Cruz), p35/p25 (Santa Cruz), and phospo-Ndel1 
(Biorbyt), and monoclonals to β-catenin (BD), dynein intermediate chain (Millipore), actin 
(Millipore), and β-III tubulin (R&D Systems). 
 
Extraction of Spinal Cord Lysates 
Spinal cord tissues were extracted from mice and homogenized in RIPA buffer (50 mM 
Tris [pH 8.0], 1 mM EDTA, 2 mM K+ EGTA, 150 mM NaCl, 10% IGEPAL, 0.5% 
deoxycholate, 0.1 SDS) supplemented with protease inhibitors. Low speed extracts were 
spun at 1,000 g, and high speed extracts were then centrifuged at 100,000 g. Lysates 
were resuspended in denaturing buffer and boiled prior to analysis by SDS-PAGE and 
Western blot. 
 
CDK5 Depletion 
Endogenous CDK5 was depleted by siRNA. As an initial estimate of the extent of 
knockdown, transfected DRG cells were lysed two days post transfection in 100 mM 
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PIPES, 1 mM EGTA, 2 mM MgCl2, 25 mM NaCl, 0.5 mM DTT, 1% Triton X-100, and 
protease inhibitors (as above). Protein was analyzed by SDS-PAGE and Western blot. 
However, transfection efficiency in DRG cultures is 30-40%, so we used 
immunofluorescence to assess the extent of knockdown in individual neurons. 
Transfected DRG cells were fixed and stained two days post transfection in 4% PFA and 
4% sucrose. Fixed cells were washed with PBS followed by blocking solution (2g BSA 
and 0.1g Saponin in 100 mL PBS) for 1 hour, then incubated with primary antibodies to 
CDK5 and tubulin, and secondary fluorescent antibodies. Knockdown was determined 
by comparing fluorescence intensities using ImageJ. 
 
Live-cell imaging  
DRG neurons were isolated according to Perlson et al. (2009) and maintained in F-12 
media (Invitrogen) with 10% heat-inactivated fetal bovine serum, 2 mM L-glutamine, 100 
U/ml penicillin, and 100 µg/ml streptomycin. For live-cell analysis, DRG neurons were 
plated on glass-bottom dishes (World Precision Instruments, Inc.) and cultured for 2 d at 
37°C in a 5% CO2 incubator. Before plating, neurons were transfected with 0.5-0.7 µg 
plasmid DNA or 20-60 pM siRNA as noted, using a Nucleofector (Lonza) according to 
the manufacturer’s specifications. 20 mM roscovitine (Cell Signaling) or DMSO was 
added as noted 24 hours prior to imaging. Imaging was performed in low fluorescence 
nutrient medium (Hibernate A; BrainBits) with 2% B27 and 2 mM GlutaMAX on an 
inverted epifluorescence microscope (DMI6000B; Leica) using an Apochromat 63x, 1.4 
NA oil immersion objective (Leica) in an environmental chamber at 37°C. Digital images 
were acquired with an ORCA-R2 (Hamamatsu Photonics) using LAS-AF software 
(Leica). Images were taken every 3 s for a total of 3 min for GFP-LC3 and DsRed2-mito, 
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every 368 ms for a total of 1.06 min for GFP-Rab7 and LAMP1-RFP, and every 500 ms 
for a total of 2 min for mRFP-TrkB.  
 
Image Analysis 
Kymographs were generated using MetaMorph. Only healthy neurons were included, as 
defined by displaying >10% motile puncta (traveling a net distance of ≥10 µm) for 
LAMP1-RFP, GFP-Rab7, and mRFP-TrkB, or >5% motile DsRed2-mito puncta. An 
exception was made for neurons expressing Lis1 K147A, where ≥5% motility of LAMP1-
RFP puncta was required for inclusion. The total number of vesicles was determined and 
normalized by kymograph length; mitochondrial size was determined by line scan. 
Fluorescent puncta were tracked from the beginning to the end of the kymograph to 
characterize motion as anterograde (≥10 µm), retrograde (≥10 µm), or non-motile (<10 
µm). To focus specifically on the interruption of highly processive motility, three puncta 
per kymograph that traveled the furthest distance over the imaging sequence in either 
the anterograde or retrograde direction were manually tracked using ImageJ, and 
assessed for total run length, run time, and number of pauses and reversals. A pause 
was defined as single or consecutive instantaneous velocities of <0.067 µm/s, the 
resolution of our system. A reversal was defined as a displacement of 1.5 µm or greater 
in the direction opposite to net cargo displacement. Peak speed was determined using 
the fastest three anterograde and retrograde cargo per kymograph. Ensemble speed 
was determined using all available vesicles, stationary or moving. All movies were 
recorded in the mid-axon, greater than 70 mm from both the axon tip and cell body. 
 
TIRF Assay for Microtubule Binding 
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HeLa cells expressing GFP-DHC (Kiyomitsu and Cheeseman, 2012) (A. Hyman, Max 
Planck Institute, Dresden, Germany) were transiently transfected with Fugene 6 (Roche) 
and harvested 20-24 hours post transfection. For microtubule binding assays, 
transfected HeLa cells were lysed in 40 mM HEPES, 1 mM EDTA, 120 mM NaCl, 0.1% 
Triton X-100, 1 mM MgATP supplemented with protease inhibitors (1 mM PMSF, 0.01 
mg/ml TAME, 0.01 mg/ml leupeptin, and 0.001 mg/ml pepstatin-A). Lysates were 
clarified by centrifugation at 1,000g and then at 100,000g. Clarified lysates were diluted 
in P12 buffer (12 mM PIPES, 1 mM EGTA, 2 mM MgCl2, pH 6.8) immediately before 
perfusion into the flow chamber. For a 70-80% confluent 10 cm plate, cells were lysed in 
100 µl lysis buffer, which was then diluted 1:20 or 1:50 for single molecule imaging. Anti-
tubulin antibody (Sigma) was incubated in flow chambers constructed as described 
(Ayloo et al., 2014) for 5 minutes, followed by blocking with 5% pluronic F-127 (Sigma) 
for 5 minutes. Rhodamine-labeled taxol-stabilized microtubules were flowed into the 
chamber and bound to the anti-tubulin antibody for 10 minutes. Cell lysates were flowed 
into the chamber with 10 U/ml hexokinase and 10 mg/ml glucose to scavenge ATP, 
along with 1 mg/ml bovine serum albumin, 1 mg/ml casein, 20 µM taxol, 1 mM DTT, and 
an oxygen scavenging system (Schroeder et al., 2012). After an initial round of imaging 
of 5 locations per chamber, 11 µl of a wash containing 10 mM MgATP was flowed into 
the chamber, and each location was re-imaged. 
Images were acquired at room temperature using a Nikon TIRF system (Perkin 
Elmer) on an inverted Ti microscope with a 100x objective and an ImagEM C9100-13 
camera (Hamamatsu Photonics) with Volocity software. Microtubules were randomly 
chosen from the TIRF field for analysis. GFP fluorescence along the microtubules was 
measured by line-scan using FIJI and orrected for background fluorescence along a line 
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of approximately equal length in the vicinity of the microtubule. Intensity values at least 
10% above background were scored to measure the length of the microtubule occupied. 
Maximum-intensity projections were normalized to the length of the microtubule. 
Microtubule co-sedimentation assays were performed transfected DHC-GFP 
HeLa cells were harvested in 80 mM PIPES, 1mM EGTA, 1mM MgCl2, and 0.5% Triton 
X-100 with protease inhibitors. Lysate were centrifuged at 1,000g and then at 100,000g, 
then the clarified lysate was combined with 5 mM taxol-stabilized microtubules and/or 10 
mM MgATP and incubated at 37oC prior to centrifugation at 39,000g to pellet the 
microtubules and bound proteins. Supernatant and pellet fractions were resuspended in 
denaturing buffer and boiled prior to analysis by SDS-PAGE and Western blot. 
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3.4 Results 
CDK5 Activation But Not Inhibition Affects the Axonal Transport of Late Endosomes and 
Lysosomes 
CDK5 has been reported to regulate the constitutive transport of lysotracker-positive 
acidic organelles (Pandey and Smith, 2011). To further investigate this possibility, we 
used live-cell imaging to examine the effects of changes in CDK5 activity on the motility 
of Rab7 and LAMP1-positive vesicles in primary dorsal root ganglia (DRG) neurons, a 
well-established model of axonal transport (Maday et al., 2012; Moughamian and 
Holzbaur, 2012; Perlson et al., 2009).  
In control neurons, Rab7-positive late endosomes and lysosomes move 
bidirectionally along the axon, with a bias toward retrograde motility (Figure 3.1B). 
Expression of a kinase-dead dominant negative CDK5 (dnCDK5) that binds to and 
sequesters p35 (Nikolic et al., 1996) did not significantly affect transport velocities 
(Figure 3.3A), the ratio of motile to stationary organelles, or the number of pauses and 
reversals observed during processive motility. Expression of the CDK5 activator p25 
also did not significantly affect the percent of Rab7-positive lysosomes demonstrating 
stationary, anterograde, or retrograde motility (Table 3.1). However, expression of p25 
led to a significant increase in the frequency of nonprocessive events interrupting rapidly 
moving organelles. This disruption was observed in cargos moving in both the 
anterograde and retrograde directions (Figure 3.1C, 3.5).  
Next, we examined LAMP1-RFP, a well-characterized reporter for the motility of 
the late endosomal/lysosomal compartment (Moughamian and Holzbaur, 2012). Similar 
to our observations with Rab7-GFP, minimal changes in the bidirectional motility of 
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Figure 3.1 Activation but not inhibition of CDK5 regulates transport of Rab7- and 
LAMP1- positive lysosomes.  
(A) When bound to the endogenous membrane-bound activator p35, CDK5 activity is 
temporally and spatially restricted. When bound to the stress-induced activator p25, 
CDK5 activity is prolonged and untethered from the membrane, leading to both temporal 
and spatial deregulation. (B) Kymographs of lysosomal motion in DRG neurites 
expressing Rab7-GFP. Representative runs are highlighted to the right of each 
kymograph: green – anterograde, red – retrograde, yellow – stationary. White arrows 
indicate individual pauses and reversals during right-most retrograde run in each panel. 
(C) While inhibition of CDK5 had no effect on the nonprocessive motion of Rab7-tagged 
lysosomes, activation of CDK5 by p25 decreased processivity. (D) Kymographs from 
DRG neurites transfected with LAMP1-RFP. Representative runs are highlighted to the 
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right of each kymograph. (E) Inhibition of CDK5 activity using multiple approaches 
including expression of a dominant negative construct (dnCDK5), depletion of 
endogenous CDK5 by siRNA, and treatment with the CDK5 inhibitor roscovitine, had no 
effect on lysosomal transport. In contrast, increasing CDK5 activity via expression of p25 
significantly increased nonprocessive events. The effects of p25 were blocked by 
expression of dnCDK5 or depletion of CDK5. Scale bars indicate 10 s and 10 µm. 
Graphs indicate means ± SEM; n=15 neurons from ≥3 experiments. Differences 
between conditions were analyzed by one-way ANOVA with Tukey’s post-hoc test. 
***p<0.001. 
 
LAMP1-positive organelles were observed upon expression of dnCDK5 (Figure 3.1D). 
We used two additional approaches to inhibit CDK5 activity: depletion of 90% of 
endogenous CDK5 using siRNA (Figure 3.2), and pharmacological inhibition with 
roscovitine (Meijer et al., 1997; Zheng et al., 2007). Neither approach led to a 
measurable effect on axonal transport, suggesting that CDK5 activity is not required to 
regulate the constitutive transport of late endosomes and lysosomes along the axon. 
In contrast, activation of CDK5 by p25 led to a significant increase in the 
frequency of nonprocessive events during directed transport of LAMP1-positive 
organelles, similar to the changes observed in Rab7-positive organelles. To test the 
specificity of this effect, we co-expressed p25 and dnCDK5, and found that the p25-
induced increase in nonprocessive motility was completely blocked by CDK5 inhibition 
(Figure 3.1E, 3.3). Similarly, depletion of CDK5 using siRNA blocked the alteration in 
motility induced by expression of p25, supporting the conclusion that the effects of p25 
are mediated by the hyperactivation of CDK5.  
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Cargo Tag  Condition  Anterograde %  Retrograde %  Stationary % 
Control 6.2 ± 0.01 16.24 ± 0.01 77.56 ± 0.01 
dnCDK5 5.42 ± 0.01 13.86 ± 0.01 80.72 ± 0.02 
Rab7 
(endosomes) 
p25 7.86 ± 0.01 16.77 ± 0.01 75.37 ± 0.02 
Control 18.67 ± 0.01 18.66 ± 0.01 62.67 ± 0.01 
dnCDK5 18.10 ± 0.01 22.18 ± 0.01 59.73 ± 0.01 
LAMP1 
(lysosomes) 
p25 15.86 ± 0.01 17.56 ± 0.01 66.58 ± 0.02 
Control 0.26 ± 0.00 55.44 ± 0.04 44.30 ± 0.04 
dnCDK5 1.08 ± 0.01 40.80 ± 0.05 * 58.11 ± 0.05 * 
LC3 
(autophagosomes) 
p25 1.91 ± 0.01 26.92 ± 0.05 *** 71.17 ± 0.05 *** 
Control 13.42 ± 0.01 15.19 ± 0.01 71.38 ± 0.02 
dnCDK5 9.73 ± 0.01 9.36 ± 0.01 80.91 ± 0.02 
Mito 
(mitochondria) 
p25 8.15 ± 0.01 9.51 ± 0.01 82.35 ± 0.02 
Control 16.55 ± 0.01 23.37 ± 0.01 60.08 ± 0.02 
dnCDK5 19.24 ± 0.02 21.95 ± 0.02 58.81 ± 0.03 
TrkB 
(signaling 
  endosomes) 
p25 19.04 ± 0.02 23.64 ± 0.02 57.32 ± 0.03 
 
Table 3.1: Varying CDK5 activity level has minimal effect on directionality of transport or 
the fraction of motile cargo.  
Condition indicates expression of CDK5 construct. Mean ± SEM. Anterograde and 
retrograde are defined as >10 microns traveled over the course of imaging. Values that 
differ significantly from control by two-way ANOVA with Tukey’s post-hoc test are 
denoted in the table (*p<0.05; ***p<0.001). 
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Figure 3.2: Depletion of CDK5 by siRNA results in 90% knockdown in individual cells 
and 60% knockdown by plate.  
(A) Targeted reduction of endogenous CDK5 via siRNA, as assessed by western blot 
versus control neurons. (B) Quantitative analysis of western blots of cell lysates suggest 
a lower limit for CDK5 knockdown of 60%, skewed by the overall transfection efficiency 
of 30-40% of neurons on the plate (graph shows means ± SEM). (C) Expression of 
CDK5 by immunoflourescence in control DRG neurons, neurons transfected with siRNA 
targeted against CDK5, and neurons without primary antibody. (D) siRNA targeted 
against CDK5 resulted in 90.4% knockdown of endogenous protein at the cellular level, 
as assessed by immunofluorescence (graph shows means ± SEM). 
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Figure 3.3: Changes in CDK5 activity have minimal effect on the velocity of bidirectional 
cargo, while activating CDK5 increases cargo density and the overall number and time 
occupied by nonprocessive events for LAMP1-positive lysosomes.  
(A) Increasing (p25) or decreasing (dnCDK5) CDK5 activity had minimal effect on the 
peak velocity of Rab7-positive lysosomes or dsRed2-labeled mitochondria. (B) 
Expression of p25 increased the density of Rab7-positive lysosomes, LC3-positive 
autophagosomes, and TrkB-positive signaling endosomes in the mid-axon. (C) 
Activation but not inhibition of CDK5 activity increased the absolute number of pauses 
and reversals undertaken by actively moving LAMP1-positive vesicles. Despite this 
increase, only slightly more time was spent paused or moving opposed to the direction 
of primary motility. (D) Kymographs of lysosome and autophagosome motion in DRG 
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neurites expressing LAMP1-RFP or GFP-LC3 and wildtype Lis1. Overexpression of 
wildtype Lis1 did not alter the appearance of lysosomal (Figure 1D) or autophagosome 
(Figure 3A) motility. Scale bars indicate 10 s and 10 µm. (E) Fragmented mitochondria 
were found along the neurites of DRG neurons in mutant SOD1 mice, but were returned 
to stereotypic long tubular mitochondria when CDK5 activity is inhibited.  
 
CDK5 Activation Disrupts Mitochondria Transport  
We next examined mitochondrial motility using the marker DsRed2-mito which labels 
both tubular and vesicular mitochondria in the axon (Figure 3.4B). Robust bidirectional 
motility of large and small mitochondria was observed (Figure 3.4A, Table 3.1). Similar 
to our observations for late endosomes/lysosomes, expression of dnCDK5, depletion of 
endogenous CDK5 by siRNA, or chemical inhibition had no effect on mitochondrial 
motility. However, p25-induced activation of CDK5 increased the number of 
nonprocessive events exhibited by actively moving mitochondria. Again, the increase in 
oscillatory motion induced by p25 expression was reduced by co-expression of dnCDK5, 
depletion of CDK5 by siRNA, or treatment with the chemical inhibitor roscovitine (Figure 
3.4D, 3.5C), indicating the specificity of the observed effects. 
p25 expression also resulted in increased fragmentation of mitochondria (Figure 
3.4B, C), as well as an increase in mitochondrial density along the axon, as previously 
noted (Meuer et al., 2007). Neurons exposed to diminished levels of CDK5 activity 
(dnCDK5, siRNA to CDK5, roscovitine), did not exhibit changes in mitochondrial density 
or fragmentation (Figure 3.4E). While co-expression of dnCDK5 or depletion of 
endogenous CDK5 by siRNA was not sufficient to block these effects, roscovitine 
treatment was sufficient to rescue the effects on mitochondrial density induced by p25.   
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Figure 3.4: CDK5 activation but not inhibition disrupts mitochondrial transport. 
(A) Kymographs of DsRed2-mito-labeled mitochondria in DRG neurites. Representative 
runs are highlighted below each kymograph: green – anterograde, red – retrograde, 
yellow – stationary. Scale bars indicate 30 s and 10 µm. (B) Long tubular mitochondria 
were found along the neurites of DRG neurons in the control and dnCDK5 conditions, 
but fragment into smaller pieces upon expression of p25. (C) Activation of CDK5 by p25 
decreased the size of mitochondria, while inhibition of CDK5 has no effect on 
mitochondrial length. (D) Activation of CDK5 increased the density of mitochondria along 
the axon. Co-expression of p25 with either dnCDK5 or siRNA against CDK5 partially 
diminished the increase in mitochondrial density. (E) Activation of CDK5 increased the 
nonprocessive motion of mitochondria. The effects of p25 were blocked by inhibition of 
CDK5. Graphs depict means ± SEM; n≥12 neurons from ≥3 experiments. Values that 
differ significantly (one-way ANOVA with Tukey’s post-hoc test) are denoted on graphs 
(*p<0.05; **p<0.01, ***p<0.001). 
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Figure 3.5: Anterograde and retrograde trafficking events are equally affected by 
changes in CDK5 activity. 
(A) Rab7-positive late endosomes display similar changes in both anterograde- and 
retrograde-directed trafficking events in response to changes in CDK5 activity. (B) 
LAMP1-positive lysosomes exhibit decreased processivity when exposed to activated 
CDK5 in both the anterograde and retrograde directions. Inhibitors of CDK5 activity have 
no effect on processivity of motion. (C) Mitochondria respond to increased CDK5 activity 
with an increase in pauses and switches in cargo moving both towards and away from 
the cell body. Inhibiting CDK5 activity does not affect motility. Graphs depict ± SEM; 
n≥12 neurons from ≥3 experiments. Values that differ significantly (one-way ANOVA with 
Tukey’s post-hoc test) are denoted on graphs (*p<0.05; **p<0.01, ***p<0.001). 
64 
 
Perturbation of CDK5 Activity Strongly Disrupts Transport of Retrograde-Biased Cargos 
Both lysosomes and mitochondria are bidirectional cargo; thus their motility results from 
the coordinated activities of both dynein and kinesins (Maday et al., 2014). To more 
directly examine the effects of CDK5 on dynein-driven transport, we imaged GFP-LC3-
positive autophagosomes (Klionsky et al., 2012; Maday et al., 2012), which move in a 
robust retrograde manner along the axon (Figure 3.6A). Autophagosome motility was 
decreased with any modulation of CDK5 activity (Table 3.1), although p25 expression 
induced the most pronounced effects. The decrease in motility and the increase in 
oscillatory events led to a striking decrease in the ensemble speed of retrograde-
directed autophagosomes induced by changes in CDK5 expression (Figure 3.6B).  
The number of pauses and reversals during autophagosome transport was 
measured in neurons overexpressing either dnCDK5 or p25. Autophagosomes displayed 
an increase in nonprocessive events when CDK5 activity was increased via p25 
expression (Figure 3.6C). Thus, autophagosomes, lysosomes, and mitochondria all 
exhibit increased pauses and switches upon CDK5 activation by p25. In contrast, 
reduction of CDK5 activity had no significant effect on the motility of lysosomes or 
mitochondria, but did reduce the ensemble speed of autophagosomes.  
 TrkB, the receptor for neurotrophic factor BDNF, moves bidirectionally in 
neurons, with a bias toward retrograde motility (Table 3.1). Reduction of CDK5 activity 
either by expression of dnCDK5 or roscovitine treatment had no effect on the transport 
of mRFP-TrkB-positive endosomes. In contrast, p25-induced activation of CDK5 led to 
oscillatory movement of TrkB, similar to effects observed for other cargos (Figure 3.6D, 
F); we also noted a decrease in the peak velocity of TrkB transport (Figure 3.6E).  
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Figure 3.6: Activation of CDK5 decreases the motility of retrograde-directed cargos. 
(A) Kymographs of autophagosomes in DRG neurites from mice expressing GFP-LC3. 
Representative runs are highlighted below each kymograph: green – anterograde, red – 
retrograde, yellow – stationary. (B) Ensemble speeds of autophagosomes decreased 
with increased CDK5 activity. (C) Activation of CDK5 increased the nonprocessive 
motion of retrograde-directed LC3 cargo. (D) Kymographs of TrkB motion in DRG 
neurites transfected with TrkB-mRFP. Representative runs highlighted to the right of 
each kymograph. (E) Speed of actively transported TrkB cargo decreased with 
increased CDK5. (F) Inhibition of CDK5 activity by dnCDK5 or the chemical inhibitor 
roscovitine had no effect on processivity of TrkB. In contrast, activation of CDK5 
increased nonprocessive motion of TrkB cargo. Scale bars indicates 10 s and 10 µm. 
Graphs depict means ± SEM; n≥15 neurons from ≥3 experiments. Values that differ 
significantly (one-way ANOVA with Tukey’s post-hoc test) are denoted on graphs 
(*p<0.05; **p<0.01, ***p<0.001). 
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Active CDK5 Promotes Dynein Binding to Microtubules  
Together, these observations indicate that increased CDK5 activity affects the transport 
of multiple axonal cargos, with the most striking effects observed for retrograde-directed 
cargos. This suggests that the retrograde motor dynein may be the target of CDK5 
activity. The binding of ATP to dynein induces the release of the motor from the 
microtubule by inducing a conformational change in dynein’s linker domain; the dynein-
binding protein Lis1 modulates this conformational change, enhancing the strongly 
bound state (Huang et al., 2012). Ndel1, a known phosphorylation target of CDK5, 
enhances the binding of Lis1 to dynein (McKenney et al., 2011; Niethammer et al., 
2000). We hypothesized that the CDK5-dependent phosphorylation of Ndel1 would 
promote the formation of a more stable Lis1/Ndel1/dynein complex and thus induce a 
sustained interaction of dynein with the microtubule. For organelles trafficking along the 
axon, this would be predicted to lead to an increase in pauses and reversals upon 
activation of CDK5 by p25. 
 To determine if the binding of dynein to microtubules is enhanced by activated 
CDK5, a microtubule-binding assay was performed using HeLa cell lysates expressing 
CDK5 or co-expressing CDK5 and p25 (Figure 3.7A). Co-expression of CDK5 and p25 
significantly enhanced the binding of dynein to microtubules in the presence of ATP as 
compared to CDK5 alone (Figure 3.7B).  
A high-resolution in vitro assay was used to determine if CDK5 affects dynein 
motility by favoring increased attachment to the microtubule. Lysates from HeLa cells 
stably expressing GFP-tagged dynein heavy chain (DHC-GFP) (Kiyomitsu and 
Cheeseman, 2012) and transfected with CDK5, or both CDK5 and p25, were depleted of 
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Figure 3.7: Activated CDK5 enhances binding of dynein to microtubules in vitro. 
(A) Extracts of HeLa cells expressing CDK5 or CDK5 and p25 were exposed to 0, 5, or 
10 mM taxol-stabilized microtubules, in the presence of 10 mM MgATP. Microtubule 
pellets were probed for the binding of dynein intermediate chain (DIC). (B) The addition 
of p25 increased dynein binding to microtubules relative to CDK5 alone (means ± SEM; 
n=4 experiments). (C) Schematic of the TIRF assay used to assess dynein binding to the 
microtubule. HeLa cells expressing DHC-GFP and endogenous levels of Lis1 and Ndel1 
were transfected with CDK5 or CDK5 and p25. Lysates from transfected cells were 
perfused into a flow chamber with rhodamine-tagged microtubules fixed to a glass cover 
slip in the presence of hexokinase and glucose to induce the rigor-bound state of dynein. 
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ATP was then added to the chambers to induce release of dynein from the microtubule. 
(D) TIRF images of a microtubule (top) and attached dynein motors. Depletion of ATP 
(hexokinase/glucose) caused decoration of microtubules with rigor-bound dynein 
(middle). Addition of 10mM MgATP in the absence of activated CDK5 induced dynein 
release from the microtubule (bottom left). In the presence of activated CDK5, ATP-
induced dissociation of dynein from the microtubules was significantly inhibited (bottom 
right). (E) Addition of ATP induced the release of dynein from microtubules in the 
presence of inactive CDK5. Individual lines on the graph indicate the change in dynein 
binding along a single microtubule before (-ATP) to after (+ATP) the addition of 10mM 
ATP. Data from 54 microtubules, 3 experiments. (F) The mean percentage of 
microtubule decorated by dynein decreased significantly when CDK5 was inactive, but 
not when active CDK5 was present (means; n≥108 microtubules from 7 chambers over 
3 experiments). *p<0.05; ***p>0.001; n.s. indicates p>0.05 (2-way ANOVA with Tukey’s 
post-hoc test). 
 
ATP and perfused into a flowchamber with rhodamine-tagged microtubules fixed to glass 
coverslips (Figure 3.7C). Total internal reflection fluorescence (TIRF) microscopy was 
used to image individual dynein motors bound to microtubules. Images of the same 
microtubules were captured before and after the addition of 10 mM Mg-ATP (Figure 
3.7D). Following addition of ATP, we observed release of dynein from the microtubule in 
lysates expressing CDK5. In contrast, the addition of ATP to lysates expressing CDK5 
and p25 did not significantly alter dynein binding from pre-ATP levels (Figure 3.7E, F). 
Together, these results demonstrate that activated CDK5 enhances the binding of 
dynein to microtubules, even in the presence of saturating ATP. 
 
CDK5 Controls Dynein Motion via a Lis1/Ndel1 Dependent Mechanism  
Our in vitro experiments indicate that activated CDK5 is sufficient to induce sustained 
binding of dynein to microtubules, but CDK5 does not directly phosphorylate dynein 
(Hallows et al., 2003). One well-characterized target of CDK5-dependent 
phosphorylation is Ndel1 (Pandey and Smith, 2011). A 2:2 complex of Lis1 and Ndel1 
binds the dynein motor (Figure 3.8A), and phosphorylation of Ndel1 enhances this 
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binding (Zyłkiewicz et al., 2011). Ndel1 contains five CDK5 phosphorylation sites: S198, 
T219, S231, S242, and T245 (Figure 3.8B) (Niethammer et al., 2000); mutating these 
five residues to alanine (Ndel1 mut) blocks the CDK5-dependent phosphorylation of 
Ndel1 (Hebbar et al., 2008).  
To determine if phosphorylation of Ndel1 by CDK5 is required to induce the 
observed effects of on dynein motility, we expressed either wild type Ndel1 or the 
unphosphorylatable Ndel1 mutant along with LAMP1-RFP. Overexpression of either 
Ndel1 construct did not affect the speed or extent of motility; co-expression of dnCDK5 
also did not disrupt lysosomal motility in the presence of either Ndel1 construct (Figure 
3.8D middle). While p25 expression increased the number of oscillatory events 
interrupting the transport of lysosomes in the presence of wild type Ndel1, expression of 
unphosphorylatable Ndel1 significantly reduced the defects in lysosomal motility caused 
by p25 expression (Figure 3.8E), supporting our hypothesis that phosphorylation of 
Ndel1 regulates CDK5-dependent changes in transport. 
Next, we asked whether the p25-induced changes in lysosomal transport were 
Lis1- dependent. Lis1 contains two regions essential for binding dynein. Mutation of 
K147 (Figure 3.8C) disrupts the binding of Lis1 to dynein but not to Ndel1 (Mesngon et 
al., 2006). We found that expression of the Lis1 K147A mutant reduced both 
anterograde and retrograde transport of lysosomes, regardless of the activity level of 
CDK5 (Figure 3.8D, far right). This reduction was accompanied by an increase in 
stationary lysosomes, but did not change lysosomal density. The same changes were 
not observed with over-expression of wild type Lis1 (Figure 3.3D). Despite the overall 
decrease in motility, some lysosomes continued to exhibit robust movement in the 
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Figure 3.8: Nonprocessive motion of degradative cargo induced by CDK5 activation 
depends on a Lis1/Ndel1/dynein mechanism.  
(A) Phosphorylated Ndel1 enhances Lis1 binding to dynein (Zyłkiewicz et al., 2011). (B) 
Ndel1 contains 5 CDK5 phosphorylation sites. All 5 sites were mutated to (Niethammer 
et al., 2000). Ndel1 also contains two dynein binding regions and a Lis1 binding region, 
as well as a coiled-coiled domain and an a-helical domain. (C) Lis1 contains a Lis-
homology domain (LH) for dimerization as well as a coiled-coil domain, and a b-propeller 
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domain that binds to dynein and Ndel1. A mutation in K147 disrupts binding to dynein 
(Mesngon et al., 2006). (D) Kymographs of lysosomal motion in neurons transfected with 
wild type Ndel1, mutant Ndel1 unphosphorylatable by CDK5, and a Lis1 K147A mutant 
that cannot bind dynein (Mesngon et al., 2006). Lysosomes were labeled with LAMP1-
RFP. (E) The increase in nonprocessive events induced by p25 was blocked by 
expression of non-phosphorylatable Ndel1. Vertical stripes indicate transfection with wild 
type Ndel1; horizontal stripes indicate transfection with unphosphorylatable Ndel1. Only 
p<0.0001 are denoted in the figure. (F) The effects of p25 expression on processivity of 
lysosomal transport were less pronounced in the setting of the Lis1 K147A mutant. (G) 
Expression of the Lis1 K147A mutation reduced the number of anterograde and 
retrograde-directed lysosomes while increasing the percent of stationary (total run 
lengths <10 µm) lysosomes compared to overexpression of a Lis1 wild type construct. 
(H) Kymographs of autophagosomes labeled with LC3-GFP in the presence of wild type 
or mutant Ndel1 and mutant Lis1. (I) The number of nonprocessive events in 
autophagosome transport was reduced in the absence of phosphorylatable Ndel1. 
Vertical stripes indicate transfection with wild type Ndel1; horizontal stripes indicate 
transfection with unphosphorylatable Ndel1. Only p<0.0001 are noted in the figure. (J) 
Variations in CDK5 activity had no effect on autophagosome transport in cells 
expressing the Lis1 mutant. (K) Expression of the Lis1 K147A mutation reduced the 
number of retrograde-directed autophagosomes while increasing the percent of 
stationary autophagosomes. Scale bars indicates 10 s and 10 µm. Graphs depict means 
± SEM; n≥16 neurons from ≥3 experiments. Values that differ significantly [one-way 
ANOVA with Tukey’s post-hoc test (E, F, I, J) or two-way ANOVA with Tukey’s post-hoc 
test (G, K)] are denoted on graphs (*p<0.05; **p<0.01, ***p<0.001), n.s. or no stars 
indicate p>0.05. 
 
presence of the Lis1 mutant, allowing for analysis of pauses and directional switches. 
Among the motile lysosomes, expression of the Lis1 mutant reduced the magnitude of 
the p25-induced increase in nonprocessive events. Although LAMP1-positive lysosomes 
exhibited a slight increase in the number of nonprocessive events when p25 was 
expressed in the presence of Lis1 K147A, this increase was minimal in comparison to 
the increase observed upon expression of p25 in the absence of the Lis1 mutant (Figure 
3.8F).  
Previous work has shown that depletion of Lis1 causes dramatic inhibition of 
lysosomal motility (Moughamian et al., 2013), consistent with our finding that decreasing 
the affinity of Lis1 for dynein reduced the number of anterograde and retrograde-directed 
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lysosomes (Figure 3.8G). Co-expression of the dominant negative CDK5 construct with 
mutant Lis1 resulted in the strongest reduction in motility.  
We also examined the effects of the Ndel1 mutant on autophagosome transport, 
as the pronounced retrograde motion of these organelles is dynein-mediated (Maday et 
al., 2012). As observed for lysosomes, GFP-LC3-labeled autophagosomes displayed 
minimal changes in transport when either wild type or unphosphorylatable Ndel1 was 
expressed, at either unmodified or diminished levels of CDK5 activity (Figure 3.8H). 
Hyperactivation of CDK5 by p25 led to a significant disruption of transport as observed 
by an increase in oscillatory events when wild type Ndel1 was overexpressed. However, 
expression of the mutant form of Ndel1 was sufficient to block the p25-induced 
disruption of autophagosome transport (Figure 3.8H, I). 
Autophagosomes, like lysosomes, displayed diminished overall transport in the 
presence of mutant Lis1, independent of any perturbations in CDK5 activity (Figure 
3.8H, K). This observation is consistent with a key role for Lis1 in dynein-mediated 
organelle transport (Moughamian et al., 2013). However, we did not observe a p25-
induced increase in nonprocessive events in the few motile puncta in the presence of 
mutant Lis1 (Figure 3.8J), supporting the model that both Ndel1 and Lis1 are necessary 
downstream effectors of CDK5/p25-induced nonprocessive motility.  
 
SOD1G93A Mice Exhibit Dysregulated CDK5 Activity 
Next, we sought to investigate a possible role for elevated CDK5 activity in driving the 
pathogenic changes in axonal transport observed in models of ALS using the well-
characterized SOD1G93A mouse. Elevated p25 expression and increased CDK5 activity 
have been previously indentified in the SOD1G37R mouse line (Nguyen et al., 2001). To 
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determine whether there is a similar activation of CDK5 in the SOD1G93A mouse, high-
speed supernatant fractions from spinal cords of 90-100 day old SOD1G93A mice and wild 
type littermate controls were probed for expression of p35 and p25 using an antibody 
that recognizes both proteins (Figure 3.9A). Quantitative analysis revealed a greater 
than two-fold increase in the p25/p35 ratio in the high-speed fraction from spinal cord 
lysates from SOD1G93A mice (Figure 3.9C), indicating activation of CDK5 in this model. 
We also probed spinal cord lysates from SOD1G93A mice and wild type littermates with a 
phospho-specific antibody to the T219 residue of Ndel1 (Figure 3.9B). Animals 
expressing mutant SOD1 exhibited almost double the level of phosphorylated Ndel1 
compared to wild type animals (Figure 3.9D). 
 
Inhibition of CDK5 Rescues Disrupted TrkB Transport in SOD1G93A Neurons 
Defects in the retrograde transport of neurotrophic factors has been proposed to 
contribute to the neuronal death characteristic of ALS (Henriques et al., 2010). 
Processive motility of signaling endosomes in neurons from SOD1G93A mice was shown 
to be disrupted by frequent pauses and switches (Perlson et al., 2009); in vivo analysis 
of transport in this model also shows enhanced pausing of cargos along the axon 
(Bilsland et al., 2010). The similarity of these observations to the nonprocessive motility 
induced by p25 expression led us to ask whether the hyperactivation of CDK5 might 
contribute to the observed deficits in axonal transport.  
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Figure 3.9: SOD1 mutant mice have deregulated CDK5 activation resulting in transport 
disruption, which can be rescued by reducing CDK5 activity.  
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(A) Western blots of low speed and high speed extracts of spinal cord from SOD1G93A 
and age-matched wild type mice with an antibody recognizing both p35 and p25. Blots 
were also stained for b-catenin. (B) Western blots of spinal cord extracts from SOD1G93A 
and wild type littermate mice with a phospho-T219 specific antibody to Ndel1. Blots were 
also stained for b-catenin. (C) An increase in p25/p35 ratio was found in high speed 
extracts from SOD1G93A mice as compared with wild type littermate mice (means ± SEM; 
n=4 mice). (D) Spinal cords from SOD1G93A mice expressed higher levels of Ndel1 
phosphorylation at CDK5 site T219 than wild type littermate animals (means ± SEM; n=6 
mice). (E) Kymographs of TrkB motion in DRG neurites from 90-100 day old SOD1G93A 
mice transfected with TrkB-mRFP in the absence and presence of roscovitine. 
Representative runs are highlighted to the right of each kymograph: green – 
anterograde, red – retrograde, yellow – stationary. (F) Expression of mutant SOD1 
increased nonprocessive motion of TrkB cargo. Reducing CDK5 activity in SOD1G93A 
neurons using roscovitine rescued the observed effects on transport (mean ± SEM; n≥18 
neurons from 3 experiments). (G) Speed of actively transported TrkB cargo decreased 
significantly in SOD1G93A mice (means ± SEM; n≥18 neurons from 3 experiments). Scale 
bars indicate 10 s and 10 microns. Values that differ significantly (Students t test [C, D], 
one-way ANOVA with Tukey’s post-hoc test [F, G]) are denoted on graphs (*p<0.05; 
**p<0.01, ***p<0.001). 
 
We assessed the effects of CDK5 inhibition on signaling endosome motility in 
DRG neurons cultured from 90-100 day old SOD1G93A mice. We observed an increase in 
the oscillatory motion of mRFP-tagged TrkB when compared to age-matched controls 
(Figure 3.9E). Importantly, the oscillatory motion observed in SOD1G93A neurons was 
diminished in the presence of the CDK5 inhibitor roscovitine suggesting that increased 
CDK5 activity was responsible for the abnormal motility (Figure 3.9F). TrkB was 
transported more slowly in neurons expressing mutant SOD1; this effect was also 
rescued by roscovitine treatment (Figure 3.9G). Parallel experiments using dnCDK5 to 
inhibit CDK5 activity did not completely restore motility, likely due to lower expression 
levels of the transfected construct in SOD1G93A neurons (data not shown). However, our 
observations with roscovitine suggest that hyperactive CDK5 contributes to the 
disruption in transport observed in this ALS model, and that CDK5 inhibition can mitigate 
the effects of mutant SOD1 on axonal transport. 
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3.5 Discussion 
Here we find that inhibition of CDK5 does not significantly affect the axonal transport of 
numerous cargos including late endosomes, lysosomes, and mitochondria. Three CDK5 
inhibitors were assessed: a dominant negative CDK5 construct, a chemical inhibitor 
(roscovitine), and depletion of endogenous CDK5 by siRNA. All three failed to affect the 
processivity, motility, or speed of bidirectional cargo. While prior work reported that 
expression of dnCDK5 induced a complete block in the transport of lysotracker-positive 
organelles (Pandey and Smith, 2011), these experiments were conducted using a model 
in which sciatic nerve crush was performed prior to DRG isolation; this procedure may 
affect downstream regulatory mechanisms. As we find that neither expression of 
dnCDK5, depletion of endogenous CDK5, nor chemical inhibition of CDK5 significantly 
affected the motility of lysosomes in wild type DRG neurons, we conclude that CDK5 
does not play a significant role in the regulation of constitutive axonal transport in this 
model. 
Although reduction of CDK5 activity had little effect on axonal transport in our 
experiments, increasing CDK5 activity significantly altered the dynamics of cargo 
transport. Expression of the CDK5 activator p25 increased the likelihood that late 
endosomes/lysosomes or mitochondria would pause or reverse direction during periods 
of directed motion. Despite the increase in nonprocessive events, these bidirectional 
cargos did not display net changes in speed (Figure 3.3A, 3.5). For lysosomes, the 
increased frequency of non-motile events was matched by a decrease in the duration of 
each event (Figure 3.3A). In the context of increased CDK5 activity, pauses were shorter 
and directional changes covered less distance before resuming the initial direction of 
motion.  
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Increased CDK5 activity more significantly altered the transport of TrkB-
positive signaling endosomes and autophagosomes; these unidirectional cargos 
exhibited reductions in peak speed when CDK5 was aberrantly activated, along with an 
increase in nonprocessive events. As retrograde cargos rely primarily on dynein for 
motility, we propose that alterations in the mechanochemistry of dynein will more 
profoundly affect their speeds. In contrast, bidirectional cargos such as lysosomes and 
mitochondria have both dynein and kinesin motors bound (Fu and Holzbaur, 2014); we 
hypothesize that the powerful kinesin motors bound to these cargos may effectively 
overcome the pausing induced by Lis1-bound dynein motors. 
In addition to decreasing processive motion of cargo, increasing CDK5 activity 
via p25 also increased cargo density in the mid-axon. This was most notable for 
mitochondria, which have been previously determined to undergo fission in the presence 
of elevated CDK5 activity (Meuer et al., 2007). Lysosomes, autophagosomes, and 
signaling endosomes also exhibited increased density upon CDK5 activation (Figure 
3.3B), but no parallel changes in organelle size were observed. It is possible that the 
increased density is due to an increase in cargo trafficking to the axons, as studies in C. 
elegans have implicated CDK5 in axonal-dendritic cargo sorting (Goodwin et al., 2012; 
Ou et al., 2010). In contrast, reducing CDK5 activity levels did not alter the density of 
cargo in the mid-axon for any of the cargos examined.  
The generalized response to increased CDK5 activity implicates a common 
regulatory mechanism. Previous studies identified Ndel1 as a phosphorylation target of 
CDK5 (Niethammer et al., 2000), leading us to hypothesize that CDK5 could affect 
transport of a wide range of cargo via the Lis1/Ndel1/dynein complex. Consistent with 
this, we found that blocking the CDK5-dependent phosphorylation of Ndel1 significantly 
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reduced the p25-induced increase in nonprocessive motility; expression of a dynein-
binding mutant of Lis1 also blocked the effects of CDK5 activation.  
The observations reported here argue that CDK5 is not involved in the regulation 
of constitutive axonal transport along the axon. Instead, our results point to a model in 
which cellular stress leads to the spatially- and temporally-unregulated activation of 
CDK, and the hyper-phosphorylation of Ndel1. This phosphorylation frees Ndel1 from 
auto-inhibition, promoting the formation of a Lis1/Ndel1/dynein complex (Bradshaw et 
al., 2013; Zyłkiewicz et al., 2011). This complex acts as a clutch (Huang et al., 2012) that 
interrupts processive motility along the axon (Figure 3.10, top). In contrast, 
dephosphorylated and auto-inhibited Ndel1 cannot bind dynein. Without the Lis1/Ndel1 
complex bound, dynein processes easily, but is prone to detach from the microtubule, as 
the clutch function of Lis1 and Ndel1 is not available to block dissociation when an 
obstacle is encountered (Figure 3.10, middle) (Huang et al., 2012). As this mechanism is 
dynein-dependent, organelles that primarily move retrograde are more strongly affected 
by changes in CDK5 levels. 
In stressed neurons, both the prolonged activation and the mislocalization of 
CDK5 induced by p25 causes Ndel1 to remain consistently phosphorylated, thus 
enhancing the formation of the Lis1/Ndel1/dynein complex and causing an increase in 
the frequency of interrupted runs of motion (Figure 3.10, bottom). As a result, enhanced 
phosphorylation of Ndel1 is pathological. Prolonging the engagement of dynein with the 
microtubule through hyperphosphorylation of Ndel1 would also be likely to transiently 
stall kinesin-driven transport, as both dynein and kinesin are bound to most cargos 
actively transported along the axon (Fu and Holzbaur, 2014). However, kinesin is more 
powerful than dynein and more likely to win a sustained tug-of-war (Hancock, 2014), 
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Figure 3.10: Model for the CDK5-dependent regulation of transport through Ndel1, Lis1, 
and dynein. 
Cargo is actively transported in the retrograde direction by dynein or the anterograde 
direction by kinesin. CDK5 is activated in healthy cells by membrane-bound p35 in a 
spatially and temporally specific manner. (TOP) Ndel1, phosphorylated by activated 
CDK5, recruits Lis1 to dynein, leading to a sustained interaction of dynein with the 
microtubule. This causes increased pausing during transport. (MIDDLE) 
Dephosphorylation of Ndel1 causes the Lis1/Ndel1 complex to release from dynein. 
Dynein pauses less often without the Lis1/Ndel1 clutch. However, without Lis1 and 
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Ndel1 to hold dynein to the microtubule, dynein is more likely to disengage when 
encountering an obstacle. (BOTTOM) In the pathologic state, p35 is cleaved into p25, 
which causes prolonged and mislocalized activation of CDK5. This in turn causes 
increased phosphorylation of Ndel1, leading to strong recruitment of Lis1 to dynein and 
subsequent disruption of transport. 
 
potentially explaining why cargos with active kinesin motors exhibit less disruption of 
motility than was observed for predominantly retrograde cargos. 
The disruption of transport induced by CDK5 activation is reminiscent of previous 
observations demonstrating enhanced pausing and switches of cargos moving along 
axons of neurons from SOD1G93A mice (Bilsland et al., 2010; Perlson et al., 2009). 
Further, both p25 levels and CDK5 activity are known to be elevated in the SOD1G37R 
mouse line (Nguyen et al., 2001). Here we confirmed this observation in the SOD1G93A 
model and tested the effects of reducing CDK5 activity. Inhibition of CDK5 rescued the 
transport defect observed in neurons from SOD1G93A mice and corrected the 
mitochondrial fragmentation phenotype (Figure 3.3E), suggesting that treatment with 
CDK5 inhibitors may restore deficits in axonal transport in affected neurons in ALS. 
CDK5 inhibitors have been shown to mitigate neurological damage in stroke models 
(Menn et al., 2010); a similar therapy may be of value in the treatment of patients with 
ALS. 
Taken together, this study highlights the differences in CDK5-dependent 
regulation of transport between healthy and stressed neurons. In healthy cells, CDK5 
has minimal effect on cargo transport. However, when hyperactivated by p25, 
mislocalized CDK5 disrupts transport by increasing the number of nonprocessive events 
for cargos including lysosomes, mitochondria, autophagosomes, and signaling 
endosomes. Further, we identify a Lis1/Ndel1-dependent mechanism by which 
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pathological activation of CDK5 leads to the misregulation of axonal transport. As 
elevated CDK5 levels seen in neurons from multiple disease models correlate with 
defects in axonal transport, these transport defects may potentially be ameliorated by 
therapeutics targeted to modulation of CDK5 activation. 
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CHAPTER 4 
CDK5-Induced Local Activation of Dynein in the 
Axon Initial Segment Regulates Polarized Cargo 
Transport and Microtubule Orientation 
 
 
Eva Klinman, Mariko Tokito, & Erika L.F. Holzbaur  
 
 
4.1 Abstract 
The axon initial segment (AIS) is a specialized region of the axon that plays a key role in 
the proper sorting of axonal and somatodendritic cargos. The molecular mechanisms 
that allow the AIS to act as a filter remain unknown. Here, we show that local activation 
of dynein by CDK5 is required to maintain AIS structural features, including length, actin 
ring integrity, and microtubule polarity. CDK5 phosphorylation of Ndel1 and subsequent 
activation of dynein is further required for proper re-routing of somatodendritic cargo 
away from the axon upon AIS entry. Disruption of CDK5 or Ndel1 results in aberrant 
dendritic and axonal localization of Golgi bodies, which then nucleate plus-end-in 
microtubules in the axon, disrupting the uniform polarity of axonal microtubules. Finally, 
we demonstrate that lack of CDK5 activation leads to mis-sorting of proteins from the 
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Golgi into axonal- or dendritic- directed vesicles. Together, these studies identify CDK5 
as a master upstream regulator of dynein, which is required for proper AIS organization, 
Golgi function, and polarized cargo sorting which are critical for neuronal function. 
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4.2 Introduction 
Neurons are uniquely polarized cells, with distinctly localized proteins and organelles in 
their dendrites, soma, and axon (Dotti et al., 1988; Lasiecka and Winckler, 2011; Maeder 
et al., 2014). In order to maintain separation between axonal and somatodendritic 
proteins, entry and exit of proteins from these compartments must be limited. An active 
or passive barrier must exist, preventing unauthorized access to the axon. The small 
region that divides the soma from the axon, the axon initial segment (AIS), fulfills this 
barrier role, although the mechanism by which somatodendritic cargos are excluded 
while axonal proteins are permitted to pass and reside in the axon remains contested 
(Hedstrom et al., 2008; Lasiecka and Winckler, 2011). 
The AIS is a specialized cellular region existing between the cell body and 
proximal axon. It contains a unique structural and functional identity not found in other 
parts of the neuron. The AIS contains a high concentration of ion channels, particularly 
voltage-gated sodium channels and cell adhesion molecules (Rasband, 2010). These 
channels are held in place by a distinct and well-organized cytoskeletal architecture 
composed of actin rings, microtubule bundles, and neurofilaments (Jones et al., 2014).  
The master organizer of the AIS, ankyrin G (AnkG), is responsible for establishing the 
unique cluster of proteins that comprise the AIS. Due to its location delineating the soma 
from the axon, the AIS directs or permits flow and transport of cytoplasmic and 
membrane-bound structures. 
A variety of mechanisms have been proposed to explain how sorting occurs at 
the AIS. One proposal involved a passive diffusion barrier at the membrane, wherein the 
flow of vesicles both into (Nakada et al., 2003) and out of (Kobayashi et al., 1992) the 
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axon would be limited. The identification of a cytoplasmic size-exclusion barrier to 
passive diffusion supported this model (Song et al., 2009). These passive diffusion 
barriers have been attributed to the dense actin cytoskeleton within the AIS (Nakada et 
al., 2003; Song et al., 2009; Winckler et al., 1999). However, no such large actin barrier 
is visible using superresolution or electron microscopy (D’Este et al., 2015; Jones et al., 
2014), although small patches of actin have been identified (Watanabe et al., 2012). 
More recently, a barrier to active transport was proposed, based on earlier observations 
of uniform polarity of microtubules within the AIS. This latter mode of exclusion relies on 
activation of the minus-end directed motor dynein to return misplaced somatodendritic 
cargo to the correct neuronal compartment (Kuijpers et al., 2016), rather than a simple 
barrier function.  
Within the AIS, dynein plays a host of important functions. It is required for proper 
polarization of microtubules (Arthur et al., 2015), exclusion of Golgi bodies from the axon 
(Zheng et al., 2008), and re-routing somatodendritic cargo to the soma for re-sorting 
(Kuijpers et al., 2016), in addition to its canonical role in retrograde-directed axonal 
cargo transport. However, the mechanism by which dynein is locally activated in the AIS, 
and the resulting regulation of dynein-dependent functions are not fully understood. 
Here, we propose that cyclin dependent kinase 5 (CDK5) is a master upstream 
regulator of dynein activation in the AIS. Inhibition of CDK5 shortens the AIS and 
disrupts both actin ring structure and microtubule polarity. Inhibition of CDK5 activity 
disrupts the filtration barrier for somatodendritic proteins in the AIS and causes mis-
localization of Golgi bodies and incorrect sorting of cargo from the Golgi. CDK5 
phosphorylation of dynein cofactor Ndel1 and the formation of a Ndel1/Lis1/dynein 
complex is required for proper microtubule organization, as well as correct trafficking of 
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somatodendritic cargo out of the AIS and back to the soma. Taken together, these 
findings highlight CDK5-dependent regulation of dynein function as integral for 
cytoskeletal integrity and barrier function in the AIS. 
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4.3 Materials and Methods 
 
Constructs and Antibodies 
Mammalian expression plasmids include Ndel1, Ndel1 5A, and Lis1 (D.S. Smith, 
University of South Carolina), p25-BFP, and dnCDK5-BFP (described in Klinman and 
Holzbaur, 2015), YFP-NavII-III (Addgene), AnkG-GFP (V. Bennett, Duke University), 
mCherry- and EGFP-EB3 (Addgene), mCherry-GM130 (M. Marks, University of 
Pennsylvania), Halo-STOP (Addgene), and NgCAM-GFP (Addgene). TfR-RFP 
(Addgene) was cloned to replace the RFP moiety with a Halo sequence, mCherry was 
inserted into the p35 plasmid to create mCherry-p35, and a GFP tag was cloned into the 
Ndel1 and Ndel1 5A plasmids. SNAPf was added to replace the mCherry tag in GM130 
to permit visualization with far-red. Antibodies obtained from commercial sources include 
rabbit-anti-AnkG (Santa Cruz), goat-anti-BFP (Santa Cruz), mouse-anti-α-tubulin 
(Sigma-Aldrich), mouse-anti-HaloTag (Promega), Alexa Fluor 405 and 488 anti-goat, 
Alexa Fluor 350, 488, 555, and 594 anti mouse, and Alexa Fluor 488 and 555 anti rabbit 
(Invitrogen and Life Sciences). Other chemical reagents include roscovitine (Cell 
Signaling) and Alexa Fluor 488 and 594 Phalloidin (Invitrogen). 
 
Primary Neuron Culture and Transfection 
Primary hippocampal neurons from E18-20 Sprague Dawley rat embryos were 
dissociated from the Neuron Culture Service Center at the University of Pennsylvania, 
as described (Wilcox et al., 1994). Neurons were plated for 6-8 hours in minimal 
essential media (MEM, Gibco) supplemented with 10% heat-inactivated fetal bovine 
serum, 1 mM sodium pyruvate, and 33 mM glucose. A full media change was then 
performed and neurons were subsequently maintained in neurobasal medium (Gibco) 
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supplemented with 2% B-27 (Invitrogen), 2mM GlutaMAX (Gibco), 33 mM glucose, 100 
U/ml penicillin, and 100 µg/ml streptomycin in a 37°C incubator with 5% CO2. Neurons 
were plated at a density of 180,000 – 230,000 cells/ml on poly-L-lysine (0.5 mg/ml; 
Sigma) coated glass bottom dishes (MatTek). On DIV 3, 1 µM AraC was added and a 
half-volume media change was performed with fresh media. DIV6 or 7 hippocampal 
neurons were transfected with 1-3 constructs as necessary using Lipofectamine 2000 
reagent (Invitrogen), and a second half-media change was performed. Neurons were 
then incubated for 16-36 hours further, prior to imaging or fixation. 
 
Live Cell Imaging 
Neurons were maintained in Hibernate E (Brainbits) supplemented with 2% B-27 and 
2mM GlutaMAX for the duration of imaging. Imaging of live cells was performed on an 
inverted epifluorescence microscope (DM1600B, Leica Camera AG) or Ultraview Vox 
spinning disc confocal system (PerkinElmer) in an environmental chamber at 37°C. 
Digital images were acquired using an ORCA-R2 (Hamamtsu), using LAS-AF software 
(Leica) or with an Ultraview Photokinesis (PerkinElmer) unit on an inverted Nikon Ti 
microscope with a C91005A0 EM-CCD (Hamamatsu) camera controlled by Volocity 
software (PerkinElmer). Images were acquired at 2 frames per second for 3 minutes for 
TfR and NgCAM, 1 frame per second for 3 minutes for EB3, and 1 frame every 2 
seconds for 2 minutes for p35.  
  
STED Fixation and Imaging 
Hippocampal neurons were isolated and cultured as above, but plated at a density of 
250,000 cells/coverslip. Coverslips (Fisherbrand 12-544A #1.5) were conditioned prior to 
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neuron plating with an overnight acid wash in 0.25% acetic acid, followed by three rinses 
in EtOH, and overnight coating with poly-L-lysine.  
At 7-8DIV, neurons were fixed in 37°C mixture of 4% PFA and 4% sucrose for 8 
minutes, washed three times with BPS, permeabilized for 5 minutes in 0.1% Triton X-
100 in BPS, and blocked for 1 hour in 5% goat serum, 1% BSA, 0.1% Triton X-100 in 
BPS. Coverslips were placed in a humidity chamber and incubated in primary antibody 
diluted in blocking buffer for 1-1.5 hours at room temperature, then washed three times 
for five minutes in BPS.  The coverslips were then incubated in a light-protected humidity 
chamber in secondary antibody diluted in blocking buffer for 1 hour, then washed three 
times for five minutes in PBS. Coverslips were then rinsed once in Mili-Q water and then 
mounted in ProLong Gold (Life Technologies). 
STED microscopy was performed on a Leica DMI 6000 Inverted laser scanning 
confocal microscope equipped with 592nm and 660nm STED depletion laser. 
 
Motility and Density Analysis 
Kymographs were generated using MetaMorph or Fiji. Density of puncta was determined 
by line scan within the first 15 frames of the video on the kymograph and normalized by 
kymograph length.  
 
Intensity and Distance Quantification 
Intensity of p35 and Ndel1 fluorescence was analyzed using Fiji. ROI were taken around 
the AIS, dendrite (>20µm from the cell body), axon (>20µm from end of the AIS), and 
background near the AIS. Each ROI was ~10µm other than the background selection, 
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which was larger. Average intensity was quantified for each region, after background 
subtraction. 
The distance over which AnkG signal persisted was acquired by STED or 
epifluorescence microscopy. In both cases, a line was drawn following the AIS and axon, 
starting at the cell body. The segment line, width of 1px, was straightened in Fiji, and the 
intensity values were exported to Excel. A rolling average was calculated for each value 
based on the 5 nearest values, to smoothen the curve. The data was then normalized to 
the maximum (maximum set to 1), and the half-maximum value was calculated using the 
starting intensity and the maximum (approximately 0.72). Individual normalized 
straightened AIS intensity measurements were aligned using the half-maximum at 0 
microns as grouped data sets in Prism (GraphPad). The end of signal intensity over 
background was determined empirically, and set at 0.4 for fixed-cell and 0.5 for live-cell 
imaging. 
 
Halo and SNAP Ligand Treatment 
Halo-tagged TfR was incubated with HaloTag TMR Ligand (Promega) or HaloTag 
Oregon Green Ligand (Promega). For single-color experiments, TMR was used. Each 
plate required 0.25µl TMR ligand diluted in 375µl culture media to create a 10x working 
stock. The 10x stock was further diluted into 1x stock using 1.8ml media and 200µl 10x 
stock per dish. Media on the plates was removed and replaced with 2ml of the media 
containing TMR ligand. The plates were returned to the incubator for 15 minutes, 
occasionally swirly the dish. Unbound ligand was then removed by rinsing twice with 2ml 
fresh warm media, and the plates were incubated in the final third wash for 30 min at 37 
degrees. Plates were then treated as normal for imaging. For dual-labeling, Oregon 
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Green (non-cell permeant) was incubated first for 15 minutes, rinsed once, and then 
incubated as above with cell-permeant TMR ligand. 
SNAP staining was performed similarly to HaloTag labeling, but neurons were 
incubated for 25 rather than 15 minutes in the presence of the label. SNAP-Cell 647-SiR 
(NE Biolabs) was used to visualize SNAPf-tagged GM130 in the far-red channel. 
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4.4 Results 
CDK5 activator p35 localizes to the AIS of hippocampal neurons 
CDK5 displays pan-neuronal expression, but under normal conditions its activity is 
spatially restricted by regulated binding to its activator, the membrane-bound protein p35 
(Dhariwala and Rajadhyaksha, 2008; Hagmann et al., 2014). To determine if the 
subcellular localization of p35, and thus CDK5 activity, is spatially regulated in neurons, 
we used live-cell imaging of 7 days in vitro (DIV) embryonic rat hippocampal neurons 
expressing RFP-tagged p35 and an AIS marker.  
Twenty-four hours after transfection, p35 was clearly visible throughout the 
neuron, with strong enrichment in the cell body. The tagged p35 could also be visualized 
along the length of hippocampal dendrites and faintly along the axon (Figure 4.1A). As 
determined by co-expression with the AIS-specific voltage-gated sodium channel NaV II-
III, p35 accumulated at higher levels in the AIS than along the rest of the proximal axon 
(Figure 4.1A, right). A direct comparison of ~10µm regions taken within the axon (>20µm 
from the distal end of the AIS), within the AIS, and within a secondary dendrite (>10µm 
from the cell body) (Figure 4.1B) demonstrate significantly increased p35 intensity in the 
AIS compared to the axon.  
Comparing the local intensity of p35 within the AIS, axon, and dendrites reveals a 
7-fold increase in p35 expression in the AIS compared to the axon, and a 3-fold increase 
compared to secondary dendrites (Figure 4.1C). This recruitment of p35 to the AIS 
implies high levels of localized CDK5 activity. This led us to question whether CDK5 
regulates aspects of AIS structure and function, in addition to its previously defined role  
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Figure 4.1 Reducing CDK5 activity shortens the axon initial segment and disrupts actin 
rings. 
(A) 8 DIV rat hippocampal neurons expressing mCherry-tagged p35 and YFP-tagged 
NaV II-III. White arrows indicate AIS region. (B) Quantification of p35 fluorescence 
intensity from the AIS, axon, and dendrite of 8 DIV hippocampal neurons. (C) 
Comparative intensity of p35 fluorescence of AIS vs. axon and AIS vs. dendrite, data 
from (B). (D) STED super-resolution images of 8 DIV rat hippocampal neurons stained 
for AnkG expression. Neurons transfected with p25 or dnCDK5 as indicated. Pink arrows 
mark beginning and end of AIS, cell body to the left. (E) Quantification of length of AnkG 
signal from super-resolution images of fixed 8 DIV neurons. Neurons aligned by 75% 
max fluorescence at 0µm. Grey arrows indicate end of AnkG intensity for inhibition, 
activation, and normal CDK5 levels. (F) Quantification of length of AnkG fluorescence 
from 7 DIV live hippocampal neurons transfected with full-length AnkG-GFP. Neurons 
aligned by 75% maximum signal set to 0µm. Grey arrows indicate end of AnkG signal for 
various CDK5 conditions. (G) STED super-resolution images of the AIS from 8 DIV rat 
hippocampal neurons stained with phalloidin. Cartoons of visible actin rings depicted 
below each image. (H) Quantification of separation between adjacent actin rings from 
STED super-resolution images of 8 DIV rat hippocampal neurons. 
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Scale bars represent 10µm in (A), 5 µm in (D), and 2µm in (G). Graphs depict means ± 
SEM; n ≥	  13 neurons from at least three biological replicates. Values that differ 
significantly (one-way ANOVA with Tukey’s post-hoc test in (B) and (H); Students t-test 
in (C)) are noted on graphs (*p < 0.05, ***p < 0.001). 
 
in regulating transport along the mid-axon of sensory neurons (Klinman and Holzbaur, 
2015). 
 
AIS length is shortened with inhibition of CDK5 activity 
Abnormal length of the AIS has been linked to several diseases, including schizophrenia 
and bipolar disorder (Buffington and Rasband, 2011). The membrane-bound protein 
AnkG is an integral protein for formation of the AIS and the localized assembly of 
associated ion channels and cytoskeletal components; it is also a frequently used 
marker of AIS length (Grubb and Burrone, 2010; Jenkins and Bennett, 2001). Previous 
work in Drosophilia melanogaster suggested that the length of the AIS varies based on 
CDK5 activity levels (Trunova et al., 2011). We wanted to determine if CDK5 has a 
similar effect on AIS length in cultured mammalian neurons via inhibition or activation of 
CDK5. 
 Morphologically mature rat hippocampal neurons were fixed after 7-8 DIV and 
stained for endogenous AnkG (Dotti et al., 1988). Super-resolution Stimulated Emission 
Depletion (STED) microscopy was used to determine the distance over which AnkG 
signal persisted along the axon (Figure 4.1D). As expected, AnkG localized to the 
cellular membrane within the AIS. Inhibition of CDK5 by either expression of a dominant 
negative construct (dnCDK5) or chemical inhibition using roscovitine shortened the 
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length over which the AnkG was found (Figure 4.1E). In contrast, activation of CDK5 by 
p25 overexpression had little effect on AIS length (Figure 4.1E). 
 Live-cell imaging of DIV 6-7 hippocampal neurons transfected with full-length 
GFP-tagged AnkG (Jenkins and Bennett, 2001) led to similar results. Live cultured 
neurons exhibited shortened regions of AnkG signal when CDK5 was inhibited, similar to 
what was observed in Drosophilia with loss of CDK5 activity. In contrast to fixed-cell 
STED imaging, but in accordance with the fly data, AnkG fluorescence extended further 
when CDK5 was highly active in living neurons (Figure 4.1F), likely due to higher 
sensitivity of tagged AnkG. Taken together, these observations suggest that CDK5 
maintains AIS length, a function that is conserved from insects to mammals. 
 
Periodic actin rings in the AIS are disrupted with CDK5 inhibition 
The CDK5-dependent change in AIS length led us to question whether other aspects of 
the AIS were altered by CDK5 activity. A prominent feature of the AIS and axonal 
cytoskeleton is concentric actin rings that line the membrane, running perpendicular to 
the length of the AIS. These parallel rings stretch from the start of the AIS down into the 
axon and display characteristic spacing of ~180nm (D’Este et al., 2015; Xu et al., 2013). 
Actin rings are predicted to provide structural support and stability to the narrow and 
otherwise fragile axon (Kevenaar and Hoogenraad, 2015; Xu et al., 2013). 
 We assessed the integrity of the actin rings upon CDK5 manipulation using 
STED super-resolution microscopy on 8 DIV fixed hippocampal neurons stained with 
fluorescently-tagged phalloidin (McIntosh et al., 2015; Xu et al., 2013). Under conditions 
of normal CDK5 activity, periodic actin rings running perpendicular to the long axis of the 
axon were observed throughout the AIS (Figure 4.1G). Activation of CDK5 by p25 
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overexpression preserved the actin ring structure, but led to smaller gaps between 
concentric rings than was observed under normal conditions (Figure 4.1H). Inhibition of 
CDK5 by roscovitine or expression of dnCDK5 caused disruption of the actin ring 
structure, such that the rings appeared disordered. In contrast to the perpendicular rings 
observed when CDK5 was active, inactive CDK5 caused the rings to form at an oblique 
angle to the length of the AIS, or to be absent altogether (Figure 4.1G, last panel). 
However, the spacing between observable parallel rings was preserved in the absence 
of CDK5 activity. Super-resolution microscopy reveals that CDK5 is necessary to 
preserve the actin cytoskeleton within the AIS, in addition to supporting AIS length. 
 
Inhibition of CDK5 alters axonal microtubule polarity  
Microtubules, like actin, are uniquely organized in the AIS and axon of mammalian 
neurons. In proximal dendrites, microtubules exhibit mixed polarity: both the plus and 
minus end of the tubulin chain can face outwards towards the end of the dendrites (Baas 
et al., 1988; Stepanova et al., 2003). In contrast, within the AIS and axon, microtubules 
are found in bundles with uniform plus-end-out polarity (Baas et al., 1988; van 
Beuningen et al., 2015; Stepanova et al., 2003) (Figure 4.2A). This organization 
facilitates the anterograde motor kinesin and retrograde motor dynein to move cargo in a 
specified direction, towards or away from the axon terminal, respectively.  
 To determine if microtubule structure is grossly disrupted in the AIS in the 
absence of CDK5, we assessed microtubule localization with super-resolution STED 
microscopy. Hippocampal neurons were fixed at 8 DIV and stained with α-tubulin (Figure 
4.7A). We observed no changes in microtubule bundle number with increased or 
decreased CDK5 activity (Figure 4.7B). However, the polarity of microtubules within the 
97 
 
 
Figure 4.2 Inhibition of CDK5 activity causes mis-polarization of microtubules in the AIS. 
(A) Schematic of microtubule polarity in axons. Magnification depicts EB3 tracking with 
the growing plus-end of axonal microtubules, oriented uniformly plus-end-out in the 
axon. (B) Kymographs of EB3 motion in 7 DIV rat hippocampal neurons expressing 
mCherry-EB3, dendrites on the left, and axons on the right. Schematic on far right 
highlights 10 anterograde-directed EB3 comets in axons (black), and any visible 
retrograde-directed EB3 comets (purple). (C) Quantification of retrograde-directed EB3 
motility in the dendrite from 7 DIV rat hippocampal neurons. (D) Quantification of 
retrograde-directed EB3 motility in the axon from 7 DIV rat hippocampal neurons. 
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Scale bar represents 10µm (horizontal) and 30 seconds (vertical). Graphs depict means ± SEM; n ≥	  14 neurons from at least three biological replicates. Values that differ 
significantly (one-way ANOVA with Tukey’s post-hoc test) are noted on graphs (*p<0.05, 
****p < 0.0001). 
 
bundles, rather than the number of bundles, determines the effectiveness of motor 
protein driven transport (van Beuningen et al., 2015). Thus, we tracked end-binding 
protein 3 (EB3), which binds to the plus-end of microtubules (Figure 4.2A), as well as the 
membrane in the AIS (Stepanova et al., 2003). As tubulin dimers polymerize, the EB3 
signal follows the growing microtubule. This creates a comet-like appearance in movies 
and short angled runs in kymographs (Figure 4.2B, first row, pink). Consistent with prior 
studies, we found that in dendrites, EB3 comets appear bi-directional, demonstrating the 
mixed polarity of microtubules within these dendrites (Maday et al., 2014; Stepanova et 
al., 2003). However, in the AIS and axon, EB3 comets are uniformly anterograde-
directed in control cells. 
Activation of CDK5 by p25 had no effect on microtubule polarity in the dendrites 
or within the AIS or axon (Figure 4.2B-D, blue). In contrast, inhibition of CDK5 led to an 
increase in the number of observed retrograde-directed EB3 comets in the AIS and axon 
(Figure 4.2B-D, purple). The number of retrograde-directed EB3 comets, and thus 
minus-end-out microtubules, increased from <1% (control and activated CDK5) to ~20% 
when CDK5 was inhibited (Figure 4.2D). This loss of uniform polarity of microtubules has 
the potential to change the trafficking of cargo within the AIS. 
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Dynein regulator Ndel1 localizes to the AIS 
CDK5 is not known to directly phosphorylate microtubules or alter their polarity. 
However, CDK5 indirectly activates the minus-end-directed microtubule motor protein 
dynein through phosphorylation of Ndel1, which controls dynein activity. Previously, we 
showed that CDK5 phosphorylation of Ndel1 leads to a high-affinity dynein state via 
formation of a phospho-Ndel1/Lis1 complex (Klinman and Holzbaur, 2015). Strong 
binding of this Ndel1/Lis1/dynein complex to the microtubule ultimately interrupts 
processive cargo transport in the mid-axon. Recently, Kuijpers et al., demonstrated that 
Ndel1 activation of dynein is important for proper sorting of somatodendritic cargo that 
enter the AIS back into the soma. We sought to determine if wild-type Ndel1 localized to 
the AIS in our system and if this localization was dependent on phosphorylation by 
CDK5. 
 As has been recently shown (Kuijpers et al., 2016), we found that wild-type Ndel1 
was enriched in the AIS (Figure 4.3A-B, left). A Ndel1 mutant in which all five CDK5 
phosphorylation sites were mutated from serine to alanine residues “5A mutant” 
phospho-deficient (Hebbar et al., 2008; Niethammer et al., 2000)) also localized to the 
AIS, although the protein was less sharply restricted (Figure 4.3A-B, right). In contrast to 
wild-type Ndel1, which was strongly restricted to the AIS, the mutant Ndel1 5A more 
obviously spread into the axon. This suggests that tight regulation of Ndel1 localization 
depends on CDK5 phosphorylation, though recruitment of Ndel1 to the AIS is 
independent of CDK5 phosphorylation. 
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Figure 4.3 Dynein cofactor Ndel1 localizes to the AIS, and requires CDK5 
phosphorylation to promote proper polarization of microtubules. 
(A) 7 DIV rat hippocampal neurons expressing Halo-tagged TfR (soma and dendritic 
marker) and GFP-tagged Ndel1 (left) or Ndel1 5A mutant (right). (B) Quantification of 
Ndel1 fluorescence intensity from the AIS, axon, and dendrite of 7 DIV hippocampal 
neurons expressing wild-type or mutant Ndel1. (C) Kymographs of EB3 motion in the 
axons of 7 DIV rat hippocampal neurons. (D) Quantification of retrograde-directed EB3 
motility in the axons of 7 DIV rat hippocampal neurons. (E) Schematic depicting 
CDK5/p35 phosphorylating Ndel1, promoting Ndel1 recruitment of Lis1 to dynein, and 
leading to interaction of dynein with the microtubule. 
Scale bars represent 10µm (horizontal) and 30 seconds (vertical). Graphs depict means ± SEM; n ≥	  21 neurons from at least three biological replicates. Values that differ 
significantly (one-way ANOVA with Tukey’s post-hoc test) are noted on graphs (*p<0.5, 
***p<0.001, ****p < 0.0001). 
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Dynein cofactors Lis1 and phospho-Ndel1 are required for maintenance of proper 
microtubule polarity in the AIS and axon 
Ndel1 requires a second protein, Lis1, to strongly affect dynein motility (Zyłkiewicz et al., 
2011). Together, Lis1 and Ndel1 form a 2:2 complex to bind dynein and cause it to latch 
onto the microtubule, thus initiating or interrupting dynein-driven transport (Klinman and 
Holzbaur, 2015; Sasaki et al., 2000). To determine if Lis1 is also required to mediate the 
effects of CDK5-driven changes in microtubule polarity within the AIS and axon, we 
assessed the movement of mCherry-tagged EB3 in 7 DIV rat hippocampal neurons 
transfected with either mutant Ndel1 5A or a mutant Lis1 construct containing a point 
mutation in its dynein binding domain (K147A). Both the Ndel1 and the Lis1 mutant 
constructs recapitulated the effects of CDK5 inhibition on EB3 comet direction, and thus, 
microtubule polarity. In the AIS and axons of transfected neurons, retrograde-directed 
EB3 comets were visible with both the Ndel1 5A and Lis1 K147A mutations (Figure 
4.3C). Quantification of retrograde-directed EB3 comets demonstrated that both the 
Ndel1 and Lis1 mutants had a significantly greater percent of minus-end-outward 
microtubules than control conditions, similar to what been observed with CDK5 inhibition 
(Figure 4.3D). 
 Taken together, these findings suggest that phosphorylation of Ndel1 is required 
for proper polarity of microtubules within the AIS and axon of mammalian neurons. As 
CDK5 activity through Ndel1 and Lis1 leads to regulation of dynein (Figure 4.3E), we 
hypothesize that the observed effects of CDK5 disruption are due to dysregulation of 
dynein activation in the AIS, consistent with the known role for dynein in controlling 
microtubule polarity (Welte, 2004; Zheng et al., 2008). We next sought to determine if 
other known functions of dynein in the AIS are affected by CDK5 inhibition. 
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Polarized trafficking of somatodendritic cargo at the AIS requires CDK5 activity 
As we have shown that disruption of CDK5 activity leads to dysregulation of the 
microtubule cytoskeleton at the AIS, we hypothesized that CDK5 activity is necessary for 
proper sorting of axon-bound and somatodendritic cellular cargo. Previous work in 
Caenorhabditis elegans demonstrated that CDK5 activity was required for proper 
trafficking of axonal cargo (Goodwin et al., 2012; Ou et al., 2010), without indicating an 
equivalent role in trafficking of non-axonal cargo. Somatodendritic cargos, such as the 
transferrin receptor (TfR), primarily localize to the dendrites and cell body of mature 
hippocampal neurons (Figure 4.4A). In control cells, TfR puncta enter the AIS at a 
constant rate, but do not proceed through the AIS to enter the axon (Figure 4.4B, top). 
Once in the AIS, they reach a stopping point, turn around, and return to the cell body or 
are exocytosed to the extracellular matrix (Petersen et al., 2014). To determine if the 
pivot within the AIS is dependent on CDK5 activity, we transfected 6 DIV rat 
hippocampal neurons with Halo-tagged TfR, an AIS marker, and a variety of CDK5 
constructs, then examined the trafficking of TfR into and out of the AIS. 
 When CDK5 was active at either basal or high levels, TfR entered the AIS, 
stopped, and returned to the cell body (Figure 4.4B, top and bottom). However, when 
CDK5 was inhibited, TfR puncta that entered the AIS passed straight through into the 
axon, where they continued to be transported in the anterograde direction towards the 
axon terminal (Figure 4.4B, middle). This led to a significant increase in TfR puncta that 
enter into the axon (Figure 4.4C). This change in the ability of somatodendritic cargo to 
aberrantly enter the axon is not the byproduct of an increase in overall cargo density, as 
the total density of TfR puncta in the AIS and axon combined remained steady despite
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Figure 4.4 CDK5 controls trafficking of somatodendritic TfR puncta. 
(A) 7 DIV rat hippocampal neuron expressing Halo-tagged TfR and GFP-tagged AnkG. 
(B) Kymographs of TfR motion in 7 DIV rat hippocampal neurons expressing indicated 
CDK5 constructs. Individual runs highlighted to the right: runs shown in pink, axon in 
light green and AIS, as determined by co-expression of NaV II-III, in dark green. Yellow 
arrow marks the same run on both the kymograph and the cartoon. Videos recorded with 
an epifluorescence microscope (left, used for further quantification) or a confocal (right, 
higher magnification). (C) Quantification of the ratio of total TfR density in the axon 
versus the total to enter the AIS and axon in 7 DIV rat hippocampal neurons transfected 
with varying CDK5 constructs. (D) Quantification of the density of TfR puncta in the AIS, 
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the axon, and total under varying CDK5 conditions in 7 DIV rat hippocampal neurons. 
(E) Quantification of the density of cytoplasmic or surface puncta, as determined by 
selective ligand addition to 7 DIV rat hippocampal neurons expressing TfR-HTC that 
make it past the AIS and into the axon.  
Scale bars represent 10µm and 10 seconds. Graphs depict means ± SEM; n ≥	  22 
neurons from at least three biological replicates. Values that differ significantly (one-way 
ANOVA with Tukey’s post-hoc test) are noted on graphs (*p<0.5, **p < 0.01, ****p < 
0.0001). 
 
changes in CDK5 activity (Figure 4.4D, right). Rather, an increase in TfR density was 
only found within the axon, while a concomitant decrease was observed in the AIS 
region of the cell when CDK5 was inhibited (Figure 4.4D, left and middle).  
 TfR is a transmembrane protein that binds to and endocytoses its receptor, 
transferrin, to deliver iron to the cell through receptor-mediated endocytosis (Bonanomi 
et al., 2006). We wanted to determine if the surface or cytoplasmic pool of TfR was most 
strongly affected by changes in CDK5 activity, and thus identify if the lack of restriction 
from the axon was due to changes in membrane or cytoplasmic barrier integrity. To 
achieve this, we washed the neurons expressing Halo-tagged TfR with a pulse of non-
cell-permeable Halo ligand, before chasing with a cell-permeable ligand of a different 
wavelength. This permitted us to sort the cytoplasmic and surface TfR by color (Figure 
4.4E). Although both groups of TfR demonstrated an increased density in the axon with 
CDK5 inhibition, the cytoplasmic pool was more strongly affected, suggesting a defect in 
microtubule-based transport rather than the failure of the cell-surface barrier. 
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Figure 4.5 Proper trafficking of somatodendritic cargo depends on dynein cofactors 
Ndel1 and Lis1, and controlled temporal activation of dynein in the AIS. 
(A) Kymographs of TfR motion in 7 DIV rat hippocampal neurons expressing a phospho-
deficient 5A Ndel1 mutant and the indicated CDK5 constructs. Individual runs highlighted 
to the right: runs shown in pink, axon in light green and AIS, as determined by co-
expression of NaV II-III, in dark green. Yellow arrow marks the same run on both the 
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kymograph and the cartoon. (B) Quantification of the density of TfR puncta in the AIS or 
the axon with varying CDK5 activity and expression of the Ndel1 or Lis1 mutant in 7 DIV 
rat hippocampal neurons. (C) Quantification of the density of TfR puncta throughout the 
axon and AIS with expression of phospho-deficient Ndel1, dynein-binding Lis1 mutant, 
and varying CDK5 conditions in 7 DIV rat hippocampal neurons. (D) Kymograph of TfR 
motion in 7 DIV rat hippocampal neurons expressing Lis1 with the K147A point mutation, 
rendering it unable to bind dynein. Individual runs highlighted to the right: runs shown in 
pink, axon in light green and AIS, as determined by co-expression of NaV II-III, in dark 
green. Yellow arrow marks the same run on both the kymograph and the cartoon. (E) 
Quantification of the density of TfR puncta in the AIS or the axon with short-term dynein 
inhibition with Ciliobrevin D in 7 DIV rat hippocampal neurons. (F) Kymograph of TfR 
motion in 7 DIV rat hippocampal neurons in the presence of the dynein inhibitor 
Ciliobrevin D. Individual runs highlighted to the right: runs shown in pink, axon in light 
green and AIS, as determined by co-expression of NaV II-III, in dark green. Yellow arrow 
marks the same run on both the kymograph and the cartoon.  
Scale bar represents 10µm (vertical) and 10 seconds (horizontal). Graphs depict means ± SEM; n ≥	  20 neurons from at least three biological replicates. Values that differ 
significantly (one-way ANOVA with Tukey’s post-hoc test) are noted on graphs (****p < 
0.0001). 
 
Proper cargo sorting at the AIS is a phospho-Ndel1 dependent process 
The observation that cytoplasmic transport of TfR was heavily influenced by changes in 
CDK5 activity led us to assess if cytoplasmic microtubule-based transport by dynein was 
the target of regulation. CDK5 does not directly phosphorylate dynein, but rather 
phosphorylates the dynein cofactor Ndel1 (Dhariwala and Rajadhyaksha, 2008; Dhavan 
and Tsai, 2001). To determine if the observed defect in sorting somatodendritic cargo 
into the axon is reliant on phosphorylation of Ndel1, and thus dynein, we transfected 
cells with the phosphodeficient Ndel1 5A construct and observed trafficking of Halo-
tagged TfR. Expression of the Ndel1 5A mutant phenocopied CDK5 inhibition and led to 
mislocalization of TfR into the axon rather than forcing TfR to return to the soma (Figure 
4.5A, B). Furthermore, TfR mislocalization could neither be rescued by CDK5 
overactivation nor exacerbated by CDK5 inhibition, suggesting that CDK5 restriction of 
TfR from the axon is solely mediated by Ndel1 phosphorylation. As with CDK5 inhibition, 
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Ndel1 5A did not increase the overall density of TfR puncta to enter the AIS, suggesting 
that the changes in axonal TfR observed are not due to higher cargo density (Figure 
4.5C). Rather, the Ndel1 mutant led to an increase in the number of TfR puncta that 
passed through the AIS and into the axon unimpeded. Altogether, this indicates that 
CDK5 acts through Ndel1 phosphorylation and dynein activation to regulate the return of 
somatodendritic cargo in the AIS to the soma. 
 
Removal of somatodendritic cargo from the AIS is a dynein-dependent process that 
requires Lis1 
To determine if Lis1 is also required to mediate the effects of CDK5 on transport of 
somatodendritic cargo, we again used the Lis1 K147A mutant. Expression of the dynein-
binding Lis1 mutant led to similar targeting changes observed with the Ndel1 5A mutant 
and CDK5 inhibition: TfR puncta were transported through the AIS and into the axon, 
rather than stopping and returning to the cell body (Figure 4.5D). As expected, the 
density of TfR puncta within the axon increased, while the density within the AIS 
decreased, without altering the total density of TfR to enter the AIS (Figure 4.5B-C). 
Taken together, these results indicate that CDK5 phosphorylation of Ndel1, complex 
formation with Lis1, and subsequent activation of dynein is required for proper transport 
of somatodendritic cargo out of the AIS and back into the cell body.  
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Temporally regulated dynein activation in the AIS is required for proper sorting of 
somatodendritic cargo 
Dynein quiescence due to CDK5 inhibition causes immediate effects, resulting from 
suspension of retrograde-directed transport. However, there are also long-term effects of 
low-affinity dynein due to gradual synthesis of mixed-polarity microtubules.  
In order to determine which of these effects of disrupted dynein activity causes 
mislocalization of cargo, we used the chemical dynein inhibitor Ciliobrevin D (Sainath 
and Gallo, 2015). Short-term incubation with Ciliobrevin D (1.5-3 hours) was used to 
determine if brief inhibition of dynein was sufficient to reproduce the targeting disruption 
of TfR seen with inhibition of CDK5 and downstream dynein cofactors. 
 We found that short-term addition of Ciliobrevin D to the culture media of 7 DIV 
rat hippocampal neurons was sufficient to cause significant redistribution of TfR puncta 
from the AIS into the axon (Figure 4.5E). Without immediate and targeted activation of 
dynein within the AIS, TfR puncta were transported through the AIS and into the axon 
(Figure 4.5F). This observation implies that the short-acting immediate function of dynein 
regulates the polarized trafficking of cargo within the AIS and directs somatodendritic 
cargo back towards the cell body.  
 
Reducing dynein activation through inhibition of CDK5 and mutant Ndel1 leads to 
changes in Golgi body localization 
Though we found that immediate dynein activation on somatodendritic cargo is 
necessary for trafficking at the AIS, short-term dynein activation does not provide a 
sufficient mechanism to explain the long-term disruption of microtubule polarity. 
Therefore, we next attempted to identify possible sites for reversed-direction 
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microtubules to stabilize and elongate. Microtubules nucleate from their slow growing 
minus end (Akhmanova and Steinmetz, 2015). Canonically, the minus end of 
microtubules are embedded in the microtubule organizing center surrounding the 
centrosome (Alieva et al., 2015); however, Golgi bodies are capable of nucleating 
microtubules independent of the centrosome (Chabin-brion et al., 2001).  We thus 
hypothesized that changes in Golgi body localization might explain the increase in mis-
oriented microtubules.  
To identify Golgi localization, we used mCherry-tagged GM130, a cis-Golgi 
matrix marker (Zhang et al., 2009), in 7 DIV hippocampal neurons. We found that under 
control conditions, Golgi bodies predominantly localized to the cell body, consistent with 
prior studies (Figure 4.6A) (Zhou et al., 2014). Inhibition of CDK5 increased the Golgi 
signal in both the axon and dendrites of hippocampal neurons (Figure 4.6B). The density 
of Golgi fragments in the dendrites increased significantly with CDK5 inhibition, but was 
not significantly altered by CDK5 overactivation, suggesting that proper Golgi body 
localization requires a baseline level of CDK5 activity (Figure 4.6C).  
 Similarly, the phosphorylation-deficient Ndel1 5A mutant led to an increase in 
Golgi fragments appearing outside of the soma (Figure 4.6D). Both axonal and dendritic 
Golgi density increased significantly compared to control neurons (Figure 4.6E), 
suggesting a phosphorylation-dependent mechanism by which CDK5 controls the 
localization of Golgi bodies. Interestingly, axonal Golgi bodies identified in dnCDK5 and 
Ndel1 5A expressing neurons also displayed increased motility (Figure 4.7C). These 
findings suggest that Golgi body restriction to the soma is CDK5-dependent and provide 
a possible locus from which mis-oriented microtubules could polymerize. 
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Reducing dynein activity increases mis-polarized microtubules associated with axonal 
Golgi bodies 
The Golgi apparatus is a known nucleation point for microtubule bundles (Chabin-brion 
et al., 2001). Therefore, we hypothesized that the plus-end-in microtubules we observed 
were in proximity to mislocalized axonal and AIS Golgi bodies. We transfected 7 DIV rat 
hippocampal neurons with an AIS marker, EB3, and GM130, in addition to CDK5 
activation or inhibition constructs or Ndel1 5A, to look at the spatial proximity of 
retrograde-directed EB3 comets to axonal Golgi bodies. 
 As expected, axonal Golgi bodies and retrograde EB3 comets were sparse in 
control and activated CDK5 conditions. Even so, the observed EB3 comets were rarely 
associated with Golgi (Figure 4.6F). However, when CDK5 was inhibited or Ndel1 was 
not phosphorylated, approximately 40% of total retrograde EB3 comets were found 
within 15µm of the nearest axonal Golgi bodies. Taken together, this suggests the 
possibility that Golgi bodies might be directly serving as a point of nucleation for mis-
oriented microtubules when CDK5 activity is disrupted. 
 
Cargo sorting at Golgi bodies is disrupted with CDK5 inhibition 
The primary function of Golgi bodies is to package and sort newly synthesized proteins 
(Gadila and Kim, 2016), although they also serve as nucleation points for microtubules. 
Somatodendritic cargo, such as TfR, is not sorted into the same vesicles that contain 
axonal cargo, such as cell-adhesion protein NgCAM (Petersen et al., 2014). We wanted 
to determine if inhibiting CDK5 also affected sorting of axonal- and dendritic- directed 
cargos. In control hippocampal rat neurons 7 DIV expressing GFP-tagged NgCAM and 
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Figure 4.6 Inhibition of CDK5 or phosphodeficient Ndel1 mutant causes mislocalization 
of Golgi bodies and mis-sorting of cargo within the Golgi apparatus. 
(A) 7 DIV rat hippocampal neurons expressing mCherry-tagged Golgi marker GM130. 
Region of the AIS designated by white arrows, as indicated by co-transfection with NaV 
II-III. Individual Golgi bodies outside of the soma indicated by yellow arrowheads. (B) 7 
DIV rat hippocampal neurons expressing mCherry-tagged Golgi marker GM130 and 
BFP-tagged dnCDK5. Region of the AIS designated by white arrows, as indicated by co-
transfection with NaV II-III. Individual Golgi bodies outside of the soma indicated by 
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yellow arrowheads. (C) Quantification of density of Golgi bodies in axons vs dendrites of 
7 DIV rat hippocampal neurons transfected with different CDK5 constructs. (D) 7 DIV rat 
hippocampal neurons expressing mCherry-GM130 and untagged Ndel1 5A mutant. 
Region of the AIS designated by white arrows, as indicated by co-transfection with NaV 
II-III. Individual Golgi bodies outside of the soma indicated by yellow arrowheads. (E) 
Quantification of density of Golgi bodies in axons vs dendrites of 7 DIV rat hippocampal 
neurons transfected with Ndel1 5A mutant. (F) Quantification of percent total retrograde 
EB3 comets originating within 15µm of the nearest Golgi body for the indicated CDK5 
activity and Ndel1 mutant in rat hippocampal axons. (G) Kymographs of Halo-tagged TfR 
with the TMR halo ligand and GFP-tagged NgCAM in the axons of 7 DIV rat 
hippocampal neurons. Black arrows indicate co-transport of NgCAM and TfR in 
individual puncta in dnCDK5 axon. (H) Quantification of TfR puncta co-transporting with 
NgCAM puncta in the axon and dendrites of 7 DIV rat hippocampal neurons under 
varying CDK5 activity. 
Scale bars represent 10µm in (A), and 5 µm and 30 seconds in (F). Graphs depict 
means ± SEM; n ≥	  18 neurons from at least three biological replicates. Values that differ 
significantly (one-way ANOVA with Tukey’s post-hoc test) are noted on graphs (*p<0.05, 
**p<0.01, ***p<0.001, ****p < 0.0001). 
 
Halo-tagged TfR, NgCAM-containing vesicles enter and proceed down the axon, while 
TfR-containing vesicles are limited to entering the AIS and returning to the soma (Figure 
4.6G, top). In the dendrite, both NgCAM and TfR move in independent vesicles, with 
NgCAM-containing vesicles often returning to the cell body.  
Inhibition of CDK5 disrupts the differential sorting of axonal and somatodendritic cargo at 
the Golgi. This results in vesicles positive for both NgCAM and TfR visible in the 
dendrites and axon (Figure 4.6G, black arrows). When CDK5 activity is preserved, either 
through wild-type expression or overactivation by p25 expression, the percent of vesicles 
containing both NgCAM and TfR is minimal (Figure 4.6G, 4.7D). However, inhibition of 
CDK5 results in a significant increase in the percent of vesicles co-transporting NgCAM 
and TfR (Figure 4.6H). This suggests a secondary problem resulting from CDK5 
inhibition, specifically mis-sorting of protein at the Golgi. CDK5 inhibition disrupts not 
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only the trafficking of axonal and somatodendritic cargo, but also the packaging of these 
cargos and the structure of the microtubule tracts along which the cargo is transported. 
 
 
Figure 4.7 CDK5 inhibition disrupts Golgi body motility and sorting but not microtubule 
bundling. 
(A) STED super-resolution images of the AIS from 9 DIV rat hippocampal neurons 
stained for α-tubulin. (B) Quantification of the number of microtubule bundles from STED 
super-resolution images of 9 DIV rat hippocampal neurons. (C) Kymographs of mCherry-
tagged GM130 in 7 DIV rat hippocampal neurons co-expressing the indicated CDK5 
condition. (D) Quantification of TfR, NgCAM, and mixed TfR + NgCAM puncta 
transporting in the axon (solid bars) or dendrite (hatched bars) of 7 DIV rat hippocampal 
neurons under varying CDK5 activity. 
Graphs depict means ± SEM; n ≥	  12 neurons from at least three biological replicates. 
Values that differ significantly (one-way ANOVA with Tukey’s post-hoc test) are noted on 
graphs (****p < 0.0001).
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4.5 Discussion 
Neurons rely on precise sorting of organelles and proteins to maintain polarized axonal 
and dendritic compartments. The principle site for sorting has been identified as 
coincident with the AIS, but there is no consensus with regard to the mechanisms 
responsible for directed trafficking. Here we identify a molecular mechanism regulated 
by CDK5 and driven by dynein in conjunction with its effectors Ndel1 and Lis1. Recent 
work demonstrated Ndel1 localization to the AIS (Kuijpers et al., 2016); we show that 
p35, the upstream activator of Ndel1 phosphorylation, is also highly enriched in the AIS. 
Further, we demonstrate that inhibition of CDK5 or abrogation of the CDK5-dependent 
phosphorylation of Ndel1 significantly affects the fidelity of sorting of somatodendritic 
cargo at the AIS.  
 Ndel1 and Lis1 act together to bind dynein and induce the formation of a high-
affinity microtubule binding state (Huang et al., 2012; Klinman and Holzbaur, 2015; 
McKenney et al., 2010; Niethammer et al., 2000; Zyłkiewicz et al., 2011). In this high 
affinity state, dynein binds tightly to the microtubule and is not disassociated by 
millimolar concentrations of ATP. This Ndel1/Lis1/dynein complex is transiently 
immobilized, as the binding of Lis1 to dynein sterically blocks the swing of the linker 
domain that is integral to the mechanochemisty of the dynein ATPase cycle (Toropova et 
al., 2014). Despite this apparent inhibitory effect, Lis1 is actually required for initiation of 
axonal transport of both larger (Yi et al., 2011) and smaller organelles (Moughamian et 
al., 2013) along the axon. The model which best reconciles these results predicts that 
the transient binding of Ndel1 and Lis1 to dynein forms a high-affinity structure that 
promotes the recruitment of the motor-cargo complex to the microtubule (Klinman and 
Holzbaur, 2015). Dissociation of Lis1 from its binding site on the dynein head domain 
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relieves this inhibition and promotes active transport (Egan et al., 2012; Lenz et al., 
2006). 
 Ndel1 is highly enriched in the AIS (Kuijpers et al., 2016), as is the CDK5 
activator p35. Thus, we can now show that Ndel1/Lis1 complex provides tightly 
controlled spatial and temporal regulation of dynein motor activity. Consistent with this 
model, inhibition or depletion of CDK5, blocking the CDK5-dependent phosphorylation of 
Ndel1, blocking the binding or Lis1 to dynein, or acutely blocking dynein activity 
pharmacologically all result in the same effect: disruption of the integrity of axodendritic 
sorting at the AIS.  
 While acute inhibition of dynein is sufficient to disrupt sorting, we also note that 
more prolonged inhibition of this pathway has multiple downstream effects on neuronal 
cytoarchitecture. First, alterations in the activity of CDK5 dramatically change both the 
length and the internal organization of the AIS. Previous work in Drosophila had noted a 
link between CDK5 activity and AIS length, thus suggesting a conserved function for the 
kinase when combined with our observations. However, we also noted an unexpected 
effect on the organization of actin rings in the AIS. These rings are a relatively recent 
discover stemming from superresolution studies (D’Este et al., 2015; Xu et al., 2013), 
and have been suggested to provide stability to the axon. The disarray in the 
organization of the actin rings observed upon dysregulation of CDK5 activity suggests 
that this kinase may be important for the maintenance of the mechanical stability of the 
axon. Further studies will be required to fully assess the effects of CDK5-dependent 
alterations on axonal integrity in response to mechanical stresses. 
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 Less surprising were the effects of altered CDK5 activity on the integrity of Golgi 
bodies. Dynein is known to maintain both Golgi localization and Golgi integrity, and 
inhibition of dynein function leads to Golgi fragmentation in nonpoarlized cells (Harada et 
al., 1998; Palmer et al., 2009). Here, we show that CDK5 is also an upstream regulator 
of dynein activity at the Golgi. In addition, our results suggest that dynein is not limited to 
maintenance of Golgi body morphology, as we note pronounced defects in the sorting of 
axonal and dendritic cargo into distinct post-Golgi vesicles when we alter CDK5 activity. 
This observation may reflect a role for dynein in sorting of cargo, such as has been 
observed with endosomes (Driskell et al., 2007; Terenzio et al., 2014). 
 Finally, we noted that inhibition of CDK5 activity lead to pronounced remodeling 
of axonal microtubules, with an observed 20% increase in misoriented, minus-end-out 
microtubules. Our results suggest that this misorganization of the normally highly 
unipolar axonal microtubule cytoskeleton may be downstream of the Golgi fragmentation 
we identified. In support of this hypothesis, we noted a significant increase in actively 
growing misoriented microtubule plus-ends in close proximity to Golgi fragments along 
the axon. 
 Overall, we identify CDK5 as a master regulator of local dynein activity within the 
AIS. Though a mechanism involving phosphorylation of Ndel1, and formation of an 
Ndel1/Lis1/dynein complex, CDK5 helps to coordinate many dynein-dependent 
processes. Without CDK5-based activation of dynein, hippocampal neurons exhibit 
disruption of the actin and microtubule cytoskeleton, mistrafficking of somatodendritic 
cargo, and disturbance of Golgi body localization and sorting. Coherence of the axon 
initial segment requires controlled dynein activity, which is regulated by CDK5. 
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 Dynein is localized throughout the neuron during development and as such can 
play diverse roles in neuronal differentiation, migration, polarity development, and pan-
neuronl transport (Lipka et al., 2013; Wynshaw-Boris, 2007). Further, failure of the filter 
function within the AIS due to changes in cytoskeletal structure have been linked to 
Alzheimer’s disease. Axon pathology in the APP/PS1 mouse model of Alzheimer’s is 
due in part to a decrease in AnkG and thus impairment of the AIS, which can be rescued 
by forced expression of AnkG (Sun et al., 2014). CDK5 activation is altered in a number 
of neurodegenerative diseases including Alzheimer’s (Su and Tsai, 2011), providing a 
potential link between the integrity of the cytoskeleton in the AIS and disease through 
CDK5. 
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CHAPTER 5 
Discussion: Ramifications of CDK5-Dependent 
Dynein Regulation 
 
 
 
 
 
Neuronal transport requires well-organized regulation of motor proteins to convey cargo 
into the disparate regions of the neuron. Specific signals are needed to direct cargo to 
the dendrites, soma, axon, and axon terminals. All together, a large variety of cargos 
undergo regulated trafficking and transport, controlled by dynein and kinesins which are 
in turn, controlled by the activity of numerous kinases and adaptor proteins. In particular, 
the work of this thesis reveals a role for the kinase CDK5 in proper priming of dynein at 
the AIS and aberrant binding of dynein to microtubules in the mid-axon. 
 
5.1 Localized Control of Dynein by CDK5 
Kinase activation is a tightly regulated process. For CDK5, activation by p35 or p39 
occurs through formation of a p35/CDK5 or p39/CDK5 complex (Ko et al., 2001) at the 
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cellular membrane and perinuclear region in non-polarized cells (Asada et al., 2008; Fu 
et al., 2006). Similarly, we demonstrate that in primary hippocampal neurons, p35 is 
specifically localized to the AIS and only found at low levels in the proximal and mid-
axon. Intriguingly, Ndel1, a phosphorylation target of CDK5, is also specifically localized 
to the AIS region. Taken together, this suggests that phosphorylation of Ndel1 by CDK5 
and formation of the Ndel1/Lis1/dynein complex may be of particular importance within 
the AIS. Since priming dynein to bind to microtubules through CDK5-dependent 
phosphorylation of Ndel1 is important in both transport initiation and transport cessation, 
the observed increase in p35/CDK5 and Ndel1 expression at the AIS explain the locally 
increased dynein function there. 
Conversely, low levels of both Ndel1 and p35 in the mid-axon imply that CDK5 
likely contributes minimally to local dynein regulation in this compartment under normal 
conditions. The mid-axon is commonly a passageway, rather than the end target of 
axonal transport. As a result, cargo tends to move smoothly through the axon, in either 
the anterograde or retrograde direction (Klinman and Holzbaur, 2015). Thus, neither 
membrane-bound p35 nor Ndel1 are required in the mid-axon, as their activity would 
interrupt otherwise processive motility. However, this observation highlights the negative 
ramifications of cleavage of p35 into p25, and subsequent lack of spatial regulation of 
CDK5 activity. Single molecule assays reveal that recruited Lis1 is capable of forcing 
dynein into persistent attachment events on microtubules, and that phosphorylated 
Ndel1 recruits Lis1 to aid in immobilization of dynein (McKenney et al., 2010; Tarricone 
et al., 2004). As a result, the presence of p25 is sufficient to induce aberrant disruption of 
directed mid-axonal transport, through a mechanism that routinely helps initiate transport 
at the beginning of the axon. 
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This discovery of location-dependent CDK5 effects might imply that other factors 
which regulate dynein, such as alternative kinases, scaffolds, or adaptors, have similar 
location-dependent effects which have yet to be elucidated (Fu and Holzbaur, 2013; 
Mitchell et al., 2012; van Spronsen et al., 2013). This would theoretically create a 
continuum along the axon and dendrites wherein specific dynein regulators (activators or 
inhibitors) are in high concentration in one location, and missing in others (Franker and 
Hoogenraad, 2013). Fine-tuned dynein regulation would thus depend on which region of 
the neuron the dynein is passing through. For example, specific phosphorylation of 
dynein intermediate chain by ERK1/2 occurs at the cell periphery, and results in 
recruitment of signaling endosomes to dynein for retrograde transport to the cell body 
(Mitchell et al., 2012). Interestingly, a clear switch from bidirectional motility to directed 
retrograde motility has been observed for a subset of axonal vesicles, and is dependent 
on a conversion from Rab5- to Rab7-positive vesicles (Deinhardt et al., 2006). It is 
possible that this switch is location-dependent, and changes when the endosomes 
reaches an appropriate location to begin robust retrograde transport. Local tubulin 
modifications or changes in actin composition or density could conceivably recruit factors 
which signal to these dynein regulators that they are in the correct location. One known 
example of actin recruiting dynein occurs through the interaction of actin-associated β-III 
spectrin with the Arp1 subunit of the dynein cofactor dynactin (Holleran et al., 2001), 
which might lead to local loading of dynein regulators. Given that Ndel1/Lis1/dynein 
complex formation enhances binding of dynein to the microtubule, this type of regulation 
would correctly predict that p35 and Ndel1 are recruited to the AIS but excluded from the 
mid-axon, as their localization likely corresponds with areas of significant CDK5-
dependent transport regulation. 
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5.2 Balance of Inhibition and Activation Determines Effects of CDK5 
Both over-activation and inhibition of CDK5 interfere with neuronal function, although the 
effects are different. Increased CDK5 activity disrupts mid-axonal transport, while 
decreased CDK5 activation impairs sorting at the AIS. Taken together, these opposing 
consequences imply that in neurons, there is a specific functional range of CDK5 
activity.  
The concept that CDK5 plays opposing roles, both positive and negative, with 
regards to cellular function is not without precedent: a similar finding has been 
demonstrated with control of synaptic plasticity in adult mice. Transgenic p35-/- mice, 
which are viable but display histological brain abnormalities, have deficits in spatial 
memory and learning and impaired hippocampal long-term potentiation and depression 
(Ohshima et al., 2005). Moreover, ablation of CDK5 in hippocampal CA1 neurons results 
in severe impairments in memory formation and retrieval, with significant changes in 
protein composition at the presynaptic region (Guan et al., 2011). CDK5 expression is 
also required for fear conditioning in cholinergic hippocampal neurons, and when 
blocked inhibits fear learning (Fischer et al., 2002). These studies demonstrate a positive 
role for CDK5 in learning and memory. In contrast, conditional knockout of CDK5 in adult 
mice brains resulted in improved performance in behavioral learning tasks and 
enhanced long-term potentiation (Hawasli et al., 2007). Furthermore, a TTBK1 mouse 
model of AD demonstrated a clear link between increased p25/CDK5 activity and 
memory impairment (Sato et al., 2008). These conflicting results indicate that CDK5 
activity can be detrimental to memory formation. Taken together, these disparate 
findings imply that CDK5 promotes memory formation and appropriate memory loss, but 
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also counteracts these changes resulting in memory impairment. In short, tight 
regulation of CDK5 activity is required for functional neuronal activity both on a 
molecular level in transport, and on a behavioral level in memory. This observation is 
reminiscent of what has been recently observed for the transcriptional regulator MeCP2, 
which causes disease under both a loss-of-function and a gain-of-function conditions 
(Lombardi et al., 2015; Na et al., 2013). 
 From a developmental standpoint, activation of CDK5 is required, but over-
activation is potentially damaging. During embryogenesis, loss of CDK5 in mammals 
results in lack of proper brain formation and embryonic lethality (Nikolic et al., 1996; 
Paglini and Cáceres, 2001). In mature animals, CDK5 loss disrupts neuronal function in 
part by aberrantly permitting cell cycle entry of post-mitotic neurons, as CDK5 is 
necessary for the continual degradation of mitotic cyclins (Veas-Pérez de Tudela et al., 
2015). However, increased CDK5 activity also has a negative effect on mature neurons, 
and p25/CDK5 is a detrimental byproduct of many neurodegenerative diseases such as 
AD, PD, HD, and motor neuron diseases (Cheung and Ip, 2012). As a result, titrating the 
activity level of CDK5 is valuable; in developing and mature neurons, CDK5 only 
functions appropriately within a specific range. 
 
5.3 CDK5 Activity and Disease 
When CDK5 is misregulated, especially when its activity has been increased via 
activation through p25, neurodegeneration occurs. Direct injury from dysregulated CDK5 
activation has been observed in patients and mouse models of AD and stroke (Meyer et 
al., 2014; Patrick et al., 1999). In AD, the Aβ form of amyloid results in a cyclical 
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increase in p25 expression, which in turn results in increase Aβ production and 
subsequent injury (Cruz et al., 2003; Lopes et al., 2010; Wen et al., 2008). In stroke, 
elevated p25 and CDK5 result in worse outcomes following ischemic injury (Mitsios et 
al., 2007). Based on these results, it is evident that p25/CDK5 is both a byproduct and a 
cause of neuronal injury. 
In both of these diseases and many more (See Section 1.4), it is tempting to use 
CDK5 inhibitors as a method of treatment. Thus far in vivo mammalian stroke models 
have demonstrated that CDK5 inhibition can be neuroprotective against post-stroke 
ischemia (Menn et al., 2010). However, all attempts to reduce CDK5 activity through 
drug treatment in humans have been met with failure due to adverse side effects. 
Partially this is due to off-target effects of the most well known CDK5 inhibitor, 
roscovitine (Cicenas et al., 2015). However, even low concentrations of the inhibitor 
disrupt regulation of neuronal processes such as dynein-mediated neuronal migration 
(Tanaka et al., 2004). For both these reasons, neuronal systems end up in disarray as a 
result of roscovitine-driven CDK5 inhibition, and as such it is not a useful therapy. 
Specific inhibitors of CDK5 exist, such as p10 (the non-activating cleavage 
product of p35 and p39) and CIP (CDK5 inhibitory peptide) (Sundaram et al., 2013; 
Zhang et al., 2012; Zheng et al., 2002). Both of these inhibitors have fewer off-target 
effects than roscovitine, but still disrupt CDK5-mediated pathways. CIP has been shown 
to aid formation of new blood vessels following hypoxia in culture, but has not been used 
in living animals (Bosutti et al., 2013). p10 is as yet untested. Ultimately, precise control 
of CDK5 activity is essential for its physiological functions, as it is both essential and 
potentially neurotoxic. Finding the right balance between inhibition and neurotoxicity will 
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be integral to determining if CDK5 will ever be a valid drug target for neurodegenerative 
diseases long-term, despite its efficacy in correcting aspects of axonal transport. 
 
5.4 Future Directions 
The ramifications of the work presented in this thesis tie together disparate parts of 
neuron biology and physiology. We now have a framework for controlling localized 
dynein priming, and the means to understand one facet of dynein motility in the AIS and 
mid-axon. However, many questions remain which were not covered in the scope of this 
work. 
 
CDK5 and the Actin Cytoskeleton in the AIS 
This thesis demonstrates novel observations on the impact of CDK5 inhibition on the 
actin cytoskeleton in the AIS. However, it is unclear how CDK5 inhibition led to 
disruption of actin rings. Further work is required to determine if CDK5-mediated 
changes in dynein motility result in mis-formation of actin rings, or whether a different 
mechanism is responsible. To determine if the results are dynein-dependent, we would 
need to explore whether inhibition of Ndel1, expression of unphosphorylatable Ndel1 5A, 
or mutations in Lis1 result in the same actin ring disruption phenotype. If Ndel1 and Lis1 
mutants phenocopy CDK5 inhibition, it indicates that actin ring stability, like other 
aspects of AIS-based CDK5 regulation, are due to activation of the Ndel1/Lis1/dynein 
complex. However, if Ndel1 5A does not abrogate correct actin ring spacing in the AIS, 
CDK5 is likely acting through a mechanism which is dynein-independent. Interestingly, 
the CDK5 activator p39 has been demonstrated to bind a myosin heavy chain, 
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suggesting the possibility that myosin interactions with actin could contribute to the 
observed phenotype (Ledee et al., 2007). However, no studies have yet linked CDK5 
activity to actin mechanistically. It is as yet undetermined how the rings are formed, 
merely that they are important for maintenance of axonal mechanical integrity and likely 
serve scaffolding purposes as well. 
 The spacing of actin rings also raises important questions for further study. We 
found that activation of CDK5 by p25 led to closer spacing of actin rings in the AIS, 
without visible disruption of ring structure. Actin ring spacing is determined by adducin 
and spectrin, which also hold the rings in place (Xu et al., 2013). Currently, there is no 
known link between CDK5 and either actin-associated protein. It is interesting to note, 
however, that the spacing between neighboring actin rings is reduced by ~30% between 
control and p25-activated CDK5 conditions, not by half, as one might expect if the 
spectrin tetramers were misaligned into dimers (Xu et al., 2013). As a result, it is unclear 
precisely how altering actin, spectrin, or adducin would result in tightening of the rings 
without removing any individual protein component. 
 
Timing of Microtubule Polarity Switch 
We found that acute activation of dynein within the AIS is sufficient to return 
somatodendritic proteins to the cell body, without a requirement for long-term 
cytoskeletal restructuring. This suggests that regulation of sorting occurs over a short 
time span. In contrast, 24 hours of dysregulated dynein, stemming from inhibition of 
CDK5 or expression of the Ndel1 5A mutant, is sufficient to observe reversed polarity 
axonal microtubules. However, the timescale over which this dynein-dependent 
regulation of microtubule orientation occurs is unknown. A number of additional 
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questions remain, including whether plus-end-in microtubules form de novo, from 
cleaved microtubule fragments which switch orientation, or from mis-oriented 
microtubules which enter the AIS from the soma. Inhibiting dynein and observing the 
direction of EB1 or EB3 comets over a prolonged time period would be sufficient to 
address most of these questions. 
 Finally, changing the polarity of microtubules did not appear to affect cargo 
sorting within the AIS. It is unclear what aspects of the AIS and axon are altered when 
microtubule polarity is mixed. It would be interesting to determine if other cargos, beyond 
TfR, or motor proteins exhibit alterations in transport under these conditions. 
 
Ndel1 Tethering 
Recently, it was suggested that Ndel1 localizes to the AIS through direct interaction with 
AnkG, and can control dynein priming while fused to AnkG at the membrane (Kuijpers et 
al., 2016). This would imply that Ndel1 is capable of remote modulation of dynein 
motility, rather than requiring the formation of an Ndel1/Lis1/dynein complex, as not all 
dynein motors and microtubules are within reach of the membrane. To date, research 
has neither suggested that Ndel1 can function at a distance, nor that it changes the 
affinity of Lis1 for dynein through any mechanism other than direct binding (McKenney et 
al., 2010). However, the recent study also demonstrated that Ndel1 was remarkably 
stable in the AIS, as demonstrated by fluorescence recovery after photobleaching 
(FRAP), lending credence to the membrane-attached theory (Kuijpers et al., 2016). 
Unfortunately, the laboratory that conducted this study did not specify many key 
elements involved in their procedure, making it hard to replicate their findings. In our 
hands, repeating the experiment resulted in two different conclusions that alternately 
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agreed that Ndel1 fluorescence over the course of 10 minutes did not recover or 
disproved their observations and demonstrated full recovery within 5 minutes, depending 
on how strongly we bleached the sample.  
The other question which arises from stable Ndel1 tethering to the membrane is 
whether the mutant Ndel1 5A has a weaker interaction with AnkG. If true, this might 
explain why the mutant construct spread further into the axon rather than remaining 
tightly localized to the AIS like the wildtype construct. It would also be useful to 
determine what signal, if any, causes release of Ndel1 from AnkG, allowing it to move 
about the cytoplasm in complex with Lis1 and dynein (Shu et al., 2004; Zyłkiewicz et al., 
2011). 
However, it is possible that there is no release signal, and Ndel1 remains 
tethered to the membrane and activates dynein remotely. In this case, there are three 
possible routes for dynein activation: Lis1 binds to Ndel1 and also acts remotely, Lis1 is 
structurally altered by Ndel1 binding and leaves the membrane to activate dynein, or 
Lis1 is only active at the membrane in proximity to Ndel1. The latter suggestion implies 
that all modulation of dynein by Ndel1/Lis1 occurs along the neuronal membrane. This 
question can be addressed by tethering Lis1 to AnkG or another membrane-bound 
protein and determining if this forced membrane localization results in aberrant 
localization of somatodendritic proteins, as would be observed if dynein is not properly 
primed. 
 
Sorting at the Golgi Body 
Sorting at the Golgi body is important for many aspects of cellular function and health. 
Although it has been previously determined that sorting into endosomes is a dynein-
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dependent process, the same has not been demonstrated for Golgi vesicles (Driskell et 
al., 2007; Terenzio et al., 2014). Rather, a group of proteins, the sorting nexins, have 
been identified which aid in determining where a newly formed vesicle should be 
transported based on vesicle content (van Weering and Cullen, 2014). However, this 
does not address the fundamental question of how individual proteins are correctly 
sorted into axonal- or somatodendritic-directed vesicles, and what role dynein plays in 
this sorting.  
Without directed sorting from Golgi bodies, proteins of all types would fail to be 
recycled or moved to their correct location, both functions which would cause dramatic 
cellular harm if disrupted. It is feasible that disruption of the integrity of Golgi-based 
sorting through inhibition of CDK5 perturbs a system that does not rely on dynein. It is, 
however, equally possible that disruption of dynein is the root cause of the observed 
sorting defect, as observations have been previously made about the role of dynein in 
sorting at endosomes (Driskell et al., 2007; Terenzio et al., 2014). Regardless of whether 
sorting is a dynein-dependent process, it would be interesting to look further into how 
sorting and turnover at the Golgi is regulated in neurons by CDK5. 
 
5.5 Conclusion 
Taken together, this work highlights the importance of CDK5 in controlling dynein-
mediated transport in the mid-axon and AIS of mammalian neurons. Both an 
overabundance of CDK5 activity and inhibition of CDK5 result in neuronal dysregulation, 
in the form of altered cargo transport and trafficking. Without CDK5, neurons cannot 
survive, but too much CDK5 activity causes neurodegeneration. CDK5 is an attractive 
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drug target for slowing neurodegenerative diseases, but as yet there is no way to keep 
CDK5 activity tightly regulated using exogenous factors. 
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